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GENERAL INTRODUCTION 
Dissertation Organization 
This dissertation consists of a general introduction, a review of the analysis and 
interpretation of immune function data, three papers, and a general summary. The paper 
entitled "Pigs are relatively resistant to dexamethasone induced immunosuppression" has been 
accepted for publication in Comparative Haematology International. The second paper 
entitled "The effect of bovine immunodeficiency-like virus infection on immune function in 
experimentally infected cattle" has been published in Veterinary Immunology and 
Immunopathology (Vol 36:91-105). The third paper will be submitted for publication. The 
references cited in each paper and the review appear at the end of the respective chapters 
under "References." 
Introduction 
Several situations exist where one would like to measure immune function. For 
example, one may wish to evaluate a potential immunomodulator. Substances that can 
stimulate the immune system could be used in a variety of situations. Similarly, one may 
wish to appraise the effects on the immune system of various management practices. Such 
information could be used to help maximize the health potential of production animals. 
Evaluating the immunocompetence of individual animals can help the clinician diagnose 
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certain conditions. Such an evaluation can also provide information to substantiate a 
prognosis. Immune function testing can identify and defme immunodeficiencies. There is 
also interest in using immune function data as a criterion in selecting animals for breeding 
purposes. Whatever the reason for evaluating the immune system, data from immune function 
assays are collected. Analyzing and interpreting immune function data present a unique set of 
problems. Idiosyncrasies of the techniques used require that special procedures be employed 
when assaying and analyzing the various immune functions. The review that immediately 
follows this introduction deals specifically with analyzing and interpreting immune function 
data. The papers that follow the review contain many examples of the data types discussed in 
the review. Each of these experiments required special attention to data analysis and 
interpretation. 
Control groups are an essential part of experimental research. It may be desirable to 
have both untreated control groups and a positive control group. For example, when 
evaluating a substance for potential immunosuppressive effects, one would like to be assured 
that immunosuppression can be measured with the techniques used. In this case, an 
experimental model for immunosuppression would be useful. Such a model would also be 
useful for evaluating immunomodulators. The target use for immunomodulators is usually in 
immunosuppressed animals. Thus, to properly evaluate an immunomodulator one should test 
the substance in immunosuppressed animals as well as in normal animals. Various 
immunosuppression models have been used. The first paper details experiments that evaluate 
dexamethasone administration as a potential immunosuppression model in pigs. 
Animal diseases can often be used effectively as models for human diseases. The 
current pandemic of Acquired Immune Deficiency Syndrome has generated great interest in 
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animal models for this disease. One candidate virus is the bovine immunodeficiency-like 
virus (BIV). The virus has antigenic and genetic similarities to the human immunodeficiency 
virus, however the effects of BIV on the bovine immune system are not fully known. The 
last two papers in this dissertation describe experiments designed to test the effects of BIV 
infection on the immune system of cattle. 
4 
PROBLEMS IN ANALYZING AND INTERPRETING IMMUNE FUNCTION DATA 
Evaluating immune function in domestic animals presents a unique set of problems. 
Developing and conducting sensitive, reproducible, meaningfiil assays that truly evaluate 
immune function is the first hurdle to cross. One must then apply those tools to biologically, 
and usually, economically important problems. Once the animals are treated, the assays are 
run, and the data are collected, one must analyze and interpret the results. A prudent scientist 
will give considerable attention to this last task while planning the experiment. This review 
will discuss various problems in analyzing and interpreting immune function data. The 
problems are discussed individually, with examples provided to illustrate relevant points. In 
some cases, statistical methods are suggested to best analyze certain types of data. In other 
instances, guidelines are offered for interpreting analyzed data. Some interpretation questions 
have no simple answers; the researcher is required to make a judgement. This review should 
help the reader be assured that his or her data are appropriately analyzed and be aware of 
pitfalls and problems in immune function data interpretation. 
Analyzing and Interpreting Antibody Titer Data 
Antibody titer data present several potential problems in their analysis and 
interpretation. Titers are usually determined using serial two fold dilutions. The titer is read 
as the reciprocal of the last dilution that gives a positive test. Rarely will the minimum 
amount of antibody required for a positive test be present at the dilution tested. For example, 
a sample with a titer of 64 may contain enough antibody to be positive at a dilution of 1:98 
but the next dilution tested was 1:128. Additionally, many of the tests used to determine titer 
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are subject to variation in end point determination. Different individuals performing the same 
test on the same sample may differ in their titer determinations. By convention, a four-fold 
difference is required to consider two titers substantially different. This convention ensures 
that for two-fold dilutions a difference of two wells is required to demonstrate a convincing 
difference. Because of this ambiguity in titer determination it is best to transform raw titer 
data using a logj transformation. Thus, there is a constant one unit difference between 
successive titers rather than an exponential increase in the magnitude of the difference. Using 
a logj transformation the difference between titers of 32 and 64 is the same as the difference 
between titers of 2 and 4. If the raw titer data were analyzed using the common parametric 
statistical tests undue weight would be placed on large titers. In a similar manner, 
presentation of raw titer data using an ordinal scale rather than a logj scale or log2 
transformed data overemphasizes differences between larger titers. 
The following graphs created from data presented in Morrow-Tesch, et. al. (1994) 
illustrate the difference between raw and logj transformed titer data (Figures 1 and 2). When 
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Figure 1. Antibody titers presented as Log^. 
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Figure 2. Antibody titers presented as actual titer. 
the data are presented as the actual titer (Figure 2) there appear to be large differences on day 
seven. The largest mean titer is two and one-half times the lowest mean titer. However, the 
graph in Figure 1 depicting logj transfonmed data indicates relatively minor differences. The 
top titer is only 25% above the lowest titer, not the 2.5X as in the other graph. The authors 
of this paper presented the data as the log2(titer). Indeed their conclusions, based on statistical 
analysis, indicate that there were no detectable differences between the three groups. 
Another problem arises when comparing titer data from two groups of animals. In 
some cases, one group may respond to the antigen of interest and produce an increase in titer, 
while the other group does not produce antibody against the antigen. When the two groups 
are compared the second group will have very little or no variation (if there was no response 
in this group all titers will be zero) in the data. There will be a marked inequity in the 
variances between the groups. This type of data is probably best analyzed with non-
parametric tests such as the Wilcoxon ranked sum test (Snedecor and Cochran, Chap. 5, 
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1967). However, in such cases statistical analysis is not really needed. One can discern that 
there is a significant difference simply by inspection of the data; one group responded while 
the other group did not respond. If there are several treatment groups in the experiment, it 
may be advisable to delete the treatment with little variation from the analysis and proceed 
with the intended parametric test to compare the other groups within the experiment. Non-
parametric tests cannot be applied to the more complicated experimental designs (e.g. split 
plot), hence a parametric method would be required to compare the groups. Dropping the 
group with little variance makes this procedure possible. 
Common questions that would be asked about antibody titers would be: Did one 
group produce more antibody, or did one group produce antibody at a quicker rate? The first 
question could be answered by comparing the groups on a single test date of interest using the 
appropriate analysis of variance for the experimental design. The question of comparing the 
rate of antibody production could be tested by comparing the amount of antibody present on 
several dates. Alternatively, one could fit a linear model to the titer data over the time period 
of interest and compare the slopes of the antibody production models for each group. It is 
preferable when testing antibody production that all animals have the same status relative to 
previous exposure to the antigen. Otherwise, previous exposure may not be equal within the 
treatment groups and would confound the results. 
Analyzing and Interpreting Lymphocyte Blastogenesis Data 
The lymphocyte blastogenesis assay is widely used in evaluating immune function of 
domestic animals. This assay measures the ability of lymphocytes to proliferate in response 
to a specific (antigen) or non-specific (mitogen) stimulus. Cell division is measured by the 
incorporation of 'H-thymidine into the new DNA produced. This incorporation is then 
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quantified using a scintillation counter. The data are often reported in one of two ways: A 
counts/min (change in counts/min - cpm) or stimulation index (SI). The stimulation index is 
obtained by dividing the cpm of the stimulated sample (mitogen or antigen) by the 
unstimulated sample for the same animal. Because this is a ratio, small changes in the 
denominator (unstimulated cpm) can result in large changes in the index. For example, 
50,000/1,000 gives a SI of 50. However, 50,000/500 gives a SI of 100. There can be a 
relatively large variance in the unstimulated cpm in any given experiment. Thus, there can be 
large differences in the SI between animals even though their stimulated cpm were similar. If 
A cpm is reported (stimulated cpm - unstimulated cpm) the data are relatively insensitive to 
changes in the unstimulated cpm, particularly if the stimulated cpm are large in comparison. 
In the above example, the two cases would give a A cpm of 49,000 and 49,500 versus 
stimulation indices of 50 and 100. Thus, reporting lymphocyte blastogenesis data using SI 
gives greater weight to the level of unstimulated proliferation, while A cpm places most of the 
emphasis on the stimulated proliferation levels. Because of these relative differences, all 
blastogenesis data presented within this dissertation are presented as A cpm. When either SI 
or A cpm are presented it is important to report the cpm for unstimulated cultures. This 
information would allow others to more effectively evaluate the data. 
When antigens are used as the stimulus for blastogenesis the stimulated and 
unstimulated cpm tend to be rather close. In this case the stimulation index may be a more 
appropriate representation of the data. Consider two samples: A (stimulated, cpm=750, 
unstimulated=250) and B (stimulated cpm=2000, unstimulated cpm=1200). Comparison of SI 
and A cpm gives very different results: SI A=3, B=1.7; A cpm A=500, B=800. In this case, 
the stimulation index represents the increased antigen stimulated proliferation relative to the 
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unstimulated proliferation more clearly than does A cpm. 
There are other considerations when analyzing lymphocyte blastogenesis data. This 
type of data is subject to a large amount of day to day variability. Therefore, if all measures 
for the experiment are not done on the same day special procedures must be used. If the 
same animals are tested multiple times on separate days a repeated measures analysis is 
needed, see the section entitled "Large amounts of data and data collected over time". If all 
animals cannot be tested on the same day see the section entitled "Comparing animals that 
can not be assayed on the same day". Unequal variances may be a problem when doing 
antigen stimulated lymphocyte blastogenesis. One group may respond while another group 
does not. Unequal variances between two groups being compared makes it incorrect to use 
parametric statistical tests such as the Student's t test or the ANOVA. In such cases, non-
parametric tests should be used (please refer to the discussion of this problem at the end of 
the titer analysis section). A difficult question to be answered with lymphocyte blastogenesis 
data is what is the biologic relevance of a change in A cpm or SI of a given size? This is a 
subjective question that all scientists must answer for themselves, and is discussed later in this 
chapter. 
Analyzing Complete Blood Count Data and White Blood Cell Subset Data 
It is important that blood cell count data be converted to the actual number of cells/^il 
rather than left as a percentage. Changes in percentages can be misleading as demonstrated in 
the following example. If one just looks at the percentages for samples #1 and #2, it appears 
that there were fewer lymphocytes and more PMNs in sample #2 relative to #1. However, 
when cell numbers are evaluated, it is clear that the number of lymphocytes is actually higher 
in #2. The percentages in a differential white blood cell count must always sum to 100. 
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Table 1. Example Blood Cell Count Data. 
#1 #2 
Total WBC (cells/mm") 9,450 16,500 
PMN % 45 58 
PMN (cells/mm®) 4253 9570 
Lymph % 49 39 
Lymph (cells/mm®) 4631 6435 
Mono % 5 3 
Mono (cells/mm®) 473 495 
EOS% 1 0 
EOS (cells/mm®) 95 0 
Thus, an increase in one population requires 
a decrease in other populations on a 
percentage basis. However, there are no 
such constraints on the actual cell counts as 
this simple example demonstrates. 
Comparing One Animal with a Normal Population 
Occasionally, one may wish to determine how one particular animal compares with 
the normal population. Usually, this animal is identified by clinical signs. An example would 
be an animal that is suspected of having an underlying immunodeficiency. There are no 
statistical tests that will compare test results from one animal with a group no matter how 
many times the individual animal is tested. However, by sampling the normal population one 
can develop a confidence interval for the normal range of values based on the mean and 
standard deviation of the sample (assuming a normal distribution the mean ± 2 Standard 
Deviations is roughly a 95% confidence interval). The test animal's values can then be 
compared to this confidence interval. An example of this type of analysis is found in Rovid, 
et al, 1995. A steer within a viral infection experiment developed elevated monocyte counts. 
The steer eventually died from a multicentric lymphosarcoma. A group of age-matched 
uninfected controls were part of the experiment. On day 161 a calculated 95% confidence 
interval for the number of monocytes/(Al in the normal cattle was 226-1,404. The calf with 
lymphosarcoma had a count of 2,930; clearly this count was well outside the reference range. 
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Cell counts for B cells and T cells were compared in a similar manner and found to be within 
the reference interval. These comparisons made it clear that the monocyte counts in this 
animal were elevated, while other cell numbers did not appear to be altered. 
Because the animals of interest in these cases are just observed and not randomly 
assigned to a treatment this is an example of an observational study. The major difficulty 
with an observational study is to identify appropriate control animals. Generally, animals of 
the same species that are reasonably healthy, and that are available to be tested are used as 
controls. The estimate of the normal population is obviously biased by using such animals. 
Animals within the population of interest (e.g. domestic beef cattle in the United States) do 
not all have an equal chance of being included in the sample. Factors such as breed, age, sex, 
housing, diet, and genetics can all play a role in an animal's response. Under most 
circumstances, it is impossible to provide ideal control animals for these individual 
observational studies. However, clinically apparent immunodeficiencies usually result from 
fairly substantial defects in the immune response. Therefore, comparisons of available healthy 
animals with the immunodeficiency suspect will often yield worthwhile information. Such a 
comparison should at least provide evidence for further study. 
Comparing Animals that can not be Assayed on the Same Day 
Another situation that requires special consideration is comparing individual animals 
that cannot be assayed on the same day. Some experimental questions preclude testing groups 
of animals in synchrony: for example, testing cows at various times relative to parturition. 
Obviously, the exact time of parturition cannot be predicted. Assays must be performed 
regularly during the period prior to the expected delivery date. Only after parturition can the 
time relative to the event be established. Unfortunately, most immune function assays that 
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involve in vitro analysis of live cells have large day to day variability, (e.g. lymphocyte 
blastogenesis). Thus, the day of assay will unequally affect the response relative to the time 
of parturition. This dilemma was solved by Kehrli et. al. (1989) in a practical manner. They 
used a separate group of reference animals that were assayed each time the assays were run. 
Then values from individual cows were converted to a percent of the reference mean on each 
day. This normalization process provided an internal control to account for day to day 
variability in the assay. 
Pretreatment Data 
When animals are randomly assigned to treatment groups there is a chance that most 
of the animals having relatively high, or low, values for one or more of the measures of 
interest will end up in a single group. The risk of this happening for at least one measure 
increases with the number of different tests used in a given experiment. It is often prudent to 
test all animals prior to treatment to ascertain any preexisting differences, particularly if a 
large number of tests will be used in the experiment. For example, in experiment two 
discussed in Chapter Two of this dissertation, neutrophil chemotactic migration was found to 
be significantly higher in one group of pigs prior to treatment. In other experiments, this 
author has encountered several other cases of significant differences between groups in one or 
more measures prior to treatment. 
There are several ways of utilizing pretreatment data. One can analyze the data in a 
manner similar to that used for the post-treatment data. If no significant differences are found 
the data could be ignored. This option does not make full use of the information in the data. 
In this case the pretreatment data is just used as a check that there were no preexisting 
differences. The data are analyzed as if no pre-treatment data were available. This type of 
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analysis was used in the next chapter of this thesis. Pigs were tested prior to, and at 3 and 27 
hours after treatment. No significant differences were found between the treated and control 
pigs prior to treatment for any of the measurements made with a single exception, neutrophil 
chemotaxis. The post treatment data were then analyzed at each time point comparing the 
treated animals to the control group. This type of analysis is simple to explain and easy to 
understand. Had there been substantial pretreatment differences this method would have been 
inappropriate. 
An analysis of covariance using the pretreatment data as the covariate makes maximal 
use of the collected information. This method of analysis increases the precision of 
randomized experiments (Snedecor and Cochran, Chap 14, 1967). An analysis of covariance 
is also probably the best way to handle cases where there are preexisting differences between 
the groups. The covariate can be used to adjust for the bias caused by differences in pre­
treatment group responses (Snedecor and Cochran, Chap 14, 1967). Neutrophil and 
lymphocyte function data from an experiment were analyzed using an analysis of covariance 
(Goff, et. al., 1991). Pigs were treated with recombinant porcine somatotropin. All animals 
were tested prior to treatment, and at two time periods after treatment. The two post-
treatment test periods were each analyzed using an analysis of covariance with the 
pretreatment data for each animal as the covariate. 
A simpler but less discriminating method of handling pretreatment data would be to 
subtract the pretreatment value from the post treatment value. This method does use the 
pretreatment values and does not ignore that information. Subtraction is simpler to perform 
than the analysis of covariance for someone unfamiliar with covariance techniques. But the 
analysis of covariance is generally a more powerful test. Another drawback of subtraction is 
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that the numbers being compaied represent a difference. The values compared may be 
negative and certainly will not represent the relative values for the raw data. Both of these 
factors make data interpretation more difficult. The least squares means calculated as part of 
an analysis of covariance do represent the raw data values quite well and are much easier to 
interpret and present. While collection of pretreatment data is not essential, this procedure 
does eliminate the possibility of unknown preexisting differences confounding the results of 
an expensive experiment. 
Large Amounts of Data and Data Collected over Time 
A thorough evaluation of various components of the immune response potentially 
yields a large amount of data. If several animals are evaluated over an extended period of 
time, the sheer amount of data may make interpretation difficult. The last portion of this 
dissertation reports on a group of seventeen steers that were tested at regular intervals over a 
three year period. A total of twenty-two measures were performed on each testing date. For 
each measure three statistical comparisons were made. With such a large number of 
comparisons there is a large probability that some of the comparisons that are significant at 
the P < .05 level are due to random chance and not an underlying difference in the group 
means. For independent comparisons one would expect, on average, one in twenty 
comparisons, to be significantly different at the P < .05 level due to random chance. The 
probability that at least one of 20 independent t-tests is significant is 0.64 (Cochran and Cox, 
pg 75, 1957). Thus, in the absence of an obvious consistent tendency in the data one must 
discern "true" differences from those representing normal variation. Using various graphs to 
visualize the data is quite helpful. For assays that are subject to a large amount of day to day 
variability it is valuable to convert the data to a percent of the control mean for each test date 
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(e.g. lymphocyte blastogenesis). The data can then be viewed as a scatter plot to discern 
consistent trends. 
Analyzing data collected over a period of time from the same group of animals can 
be problematic. One often does not know if or when the treatment of interest may affect 
immune function. Therefore, multiple post-treatment testing dates are scheduled. The data 
are often analyzed on each day separately. This is a valid analysis, particularly if one expects 
a relatively transient effect of the treatment. If one expects a longer term effect, it would be 
better to perform a repeated measures analysis on the data. A repeated measures analysis 
tests for differences between experimental groups that have been measured repeatedly. All 
the data is pooled and used to see if there is a difference between the groups over the entire 
period. If the animals have been tested over an extended period one can divide the data into 
periods (e.g. Week 1, Week 2; or Year 1, Year 2) and analyze the data within each period. 
Least squares means can be calculated from the repeated measures analysis for each period. 
These means, that represent the group response during the entire period, offer a concise way 
of summarizing the data. Both of these methods are used in later chapters of this dissertation. 
A repeated measures analysis reduces the total number of comparisons and would thus reduce 
the number of significant differences detected at the P < .05 level that were simply due to 
random variation. However, as with any summary technique some of the information 
contained within the data is lost. The analysis method chosen to summarize the data should 
be consistent with the research objectives. For example, if the experimental goal is to 
evaluate long term changes in immune ftinction, then analyzing the data from long periods is 
appropriate. In this case, the information about short term changes is sacrificed in order to 
obtain a clearer picture of long term differences. 
16 
Statistical Power 
Well planned experiments include such things as proper controls, randomization of 
treatments to experimental units, and planned statistical comparisons. Another important 
characteristic of a good experiment is adequate statistical power. Most researchers always 
consider the Type I error rate of an experiment. The selected level of significance (a, e.g. 
P < .05 ) controls the Type I error rate. A Type I error occurs when one concludes that the 
null hypothesis is wrong when, in fact, it is correct. For example, one concludes that there is 
a significant difference between the means of the treated and control groups, when in fact the 
difference observed merely represents normal variation within the population (i.e. random 
chance). One can control the Type I error rate directly by selecting the level required for 
significance (e.g. P < .05, or P < .01). The Type II error rate (P) is controlled indirectly. A 
Type II error occurs when one fails to detect that a difference between the group means does 
exist. The power of a statistical test is directly related (power=l-P) to the Type II error rate. 
A statistical test that has low power will be unable to detect moderate differences between 
group means. Good practice demands that the power, or ability to discriminate, be kept as 
high as possible in an experiment. Unfortunately, Type I and Tj'pe II error rates are inversely 
related. Selecting a smaller value for a (p < .01) will increase p, the Type II error rate, and 
decrease the power of the test. Increasing the number of experimental units will increase 
experimental power, as will decreasing experimental error (e.g. using blocks), or increasing a 
(Zolman, 1993). Conducting an experiment that possesses too low of power is simply a waste 
of valuable resources. 
There are computer programs available that can be used to calculate statistical power 
(Borenstein and Cohen, 1988; Dalial, 1988; Dubin and Herr, 1986). Expected treatment 
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effect, population error variance and sample size are the variables one must estimate in order 
to calculate power. Larger sample sizes, larger treatment effects, and smaller error variances 
all work to increase statistical power. By estimating the other quantities and selecting a 
specific power level (or Type II error level) one can calculate the needed sample size. 
Miscellaneous 
For assays with known sensitivity, it is important to always report the mean and 
standard deviation of the raw data even if only transformed data are presented (e.g. percent of 
control). The raw data values provide others a means of assessing whether that assay was 
providing reasonable results. To high or too low of values for the mean or standard deviation 
may indicate technical or procedural difficulties with the assay. Data that are transformed to 
a percentage or other ratio do not allow such evaluation. 
Control groups are an essential part of any controlled experiment. Usually, an 
untreated control group is the most commonly used comparison. However, there are cases 
where other control groups could be helpful. When one is trying to evaluate a substance for 
potential immunomodulating activity, it would be helpful to have an immunosuppressed 
(and/or immunoenhanced) control group. This positive control group would ensure that the 
assays used could, in fact, detect differences in immune function. The immunomodulating 
model should be chosen to mimic as closely as possible the treatment of interest. Chapter 
Two of this dissertation chronicles studies that are investigating the use of dexamethasone 
administration as a model of immunosuppression in the pig. This work was undertaken to aid 
in the immunotoxicologic evaluation of recombinant porcine somatotropin (Goff, et. al., 
1991). Without the use of such a positive control, one can not be entirely sure if the failure 
to detect immunomodulating activity was due to a lack of activity by the substance in 
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question or due to the use of insensitive assays. 
Biologic Relevance 
The ultimate goal of immune function testing is to be able to relate the research 
findings to the actual immune response of the animal. Several errors are possible when trying 
to generalize research results. The tests one performs must have adequate sensitivity and 
specificity to detect changes in immune function. If one measures phagocytosis of yeast 
particles by neutrophils, one has little sensitivity. Because of the size of the yeast, neutrophils 
can ingest very few organisms. To observe a significant difference in this test, it would 
probably require that one group of animals have almost no neutrophil phagocytic ability while 
the other group was normal. The test could differentiate between phagocytosis ability and 
inability, but is not able to sensitively discriminate in-between those extremes. Thus, a 
finding of no significant difference between treated and control does not provide good 
evidence of normal function. In fact, one must remember a finding of no statistically 
significant difference between treated and control groups indicates that there is little evidence 
that the mean group responses are different. There may in fact be a difference but it is not 
discemable with the methodology used (see discussion on statistical power). The researcher is 
responsible for deciding if the experiment was indeed sensitive enough to detect a biologically 
relevant difference before concluding that there is no difference between treated and control 
animals. 
What amount of decreased function has biologic relevance? This question is difficult 
to answer. If one has a sensitive test one may be able to infer what levels are relevant. For 
example, dexamethasone treatment or bovine viral diarrhea virus (BVDV) infection are known 
to predispose cattle to infections that neutrophils should prevent. When normal cattle are 
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treated with dexamethasone or BVDV neutrophil functions were observed to be decreased by 
a certain percent (Roth et al. 1981ai&b; Roth et al. 1982; Kaeberle et al. 1984; Pruett et al. 
1987) This suggests that a decrease of that percentage for those neutrophil functions is 
clinically significant. However, this evidence is circumstantial and not direct. This line of 
reasoning is used in the last chapter of this dissertation to suggest that the observed changes in 
cattle infected with bovine immunodeficiency-like virus may be clinically relevant. 
The immune system is very complex and interrelated with other body systems. One 
is often limited in the portions of the immune response that one can measure. Just like the 
blind men who all felt the elephant, the portion of the immune response that is examined, may 
incorrectly influence one's perception of the overall system. Certainly, any changes observed 
are most likely not the only ones present in the animal. Similarly, the lack of any observed 
changes leaves open the possibility that other aspects of the immune response are changed. 
Evaluating immune functions of domestic animals is a challenging undertaking. 
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PIGS ARE RELATIVELY RESISTANT TO DEXAMETHASONE INDUCED 
IMMUNOSUPPRESSION 
A paper published in Comparative Haematology International (1994,4:218-225) 
Kevan P. Flaming, Belinda Lawler GofF, Dagmar Endorf Frank, James A. Roth. 
Abstract 
Dexamethasone administration has been widely used as a model of 
immunosuppression in various species. The objective of the work reported here was to 
evaluate immune function in pigs treated with dexamethasone. Experiment 1 pigs were 
assigned to either Control (n=10) or 2 mg/kg Dexamethasone (n=10) treated groups. 
Treatments were administered 48 and 24 hours prior to immune function testing. The 
dexamethasone treated pigs received the drug on 22 of 72 experimental days. Pigs in 
Experiment 2 were assigned to one of three groups: Control (n=10), 2 mg/kg dexamethasone 
(n=10), or 6 mg/kg dexamethasone (n=10). Treatments were given once and immune 
functions were evaluated three and 27 hours after treatment. Lymphocyte blastogenesis, total 
and difTerential white blood cell count, and several measures of in vitro neutrophil function 
were measured in both experiments. Antigen specific antibody production, growth rate, and 
organ weights at necropsy were also measured in Experiment 1. There were no consistent 
changes in neutrophil functions in these experiments. Lymphocyte blastogenesis to 
concanavalin A and poke weed mitogen was significantly (P<0.05) enhanced during 
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Experiment 1 in dexamethasone treated pigs; antigen specific antibody production was not 
altered by treatment. Dexamethasone treatment (both 2 and 6 mg/kg) in Experiment 2 caused 
a profound (P<0.02 - 0.01) decrease in lymphocyte blastogenesis to all three mitogens tested 
at three hours after treatment. Lymphocyte proliferation returned to control levels in the 
dexamethasone treated groups by 27 hours after treatment in Experiment 2. Dexamethasone 
treatment was also associated with a relative neutrophilia and lymphopenia in both 
experiments. Dexamethasone treated pigs in Experiment 1 grew slower, had larger livers and 
kidneys, but smaller spleens than control animals. The transient decrease in lymphocyte 
blastogenesis, lack of consistent changes in neutrophil fijnction, and unaltered antibody 
production despite treatment with large doses of dexamethasone indicates that pigs are 
remarkably resistant to immunosuppression by this drug. 
Introduction 
Dexamethasone administration is a good model of immunosuppression in cattle. This 
model is humane, repeatable, and easy to use. The suppression of lymphocyte blastogenesis, 
antibody production, and a variety of neutrophil functions has been consistently documented 
in cattle (Roth et al. 1981; Roth et al. 1982; Kaeberle et al. 1984; Pruett et al. 1987). An 
easily reproducible immunosuppression model is useful as a control when attempting to 
determine the influence of a potential immunosuppressant or immunostimulant. 
During the design of an immunotoxicology experiment, dexamethasone administration 
was selected as a likely model for immunosuppression in pigs. Dexamethasone is often used 
in pigs to recrudesce a latent porcine herpes virus (pseudorabies virus) (Mengeling, 1989; 
Schoenbaum et al. 1990; Thawley et al. 1984; Wittmann et al. 1983). Additionally, Cortisol 
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has been shown to suppress porcine lymphocyte blastogenesis in v/7/'o(Westiy et al. 1984), and 
down regulate IL-1 beta mRNA expression in porcine alveolar macrophages (Huether et al. 
1993). However, a preliminary experiment in our laboratory did not detect any consistent 
decrease in immune function after dexamethasone treatment in pigs. In cattle, a dose of 0.04 
mg/kg dexamethasone given 24 hours prior to blood collection for in vitro immune function 
testing is consistently immunosuppressive, affecting lymphocyte blastogenesis to mitogens, 
and a wide variety of neutrophil functions (Roth et al. 1981; Roth et al. 1982; Kaeberle et al. 
1984; Pruett et al. 1987). The preliminary work in pigs evaluated four doses of 
dexamethasone. The doses ranged from 10 fold lower (0.004 mg/kg) to 50 fold higher 
(2 mg/kg) than the usual cattle dose of 0.04 mg/kg. There were six pigs per treatment group, 
which were treated 24 hours prior to blood collection for immune function testing. Samples 
were collected to evaluate lymphocyte blastogenesis to mitogens, antigen specific IgG 
production, a broad range of neutrophil functions, and some basic hematologic parameters. 
None of the dexamethasone dosages studied convincingly suppressed porcine immune 
functions. 
In a subsequent experiment, 2 mg/kg dexamethasone, was administered twice, at 48 
and 24 hours prior to blood collection for cell function analysis. The data from this 
experiment are reported in this paper as Experiment 1. 
Work by Saulnier, et al. (1991) reported a significant decrease in lymphocyte 
blastogenesis to mitogens and in vitro IL-2 production three hours after administration of 6 
mg/kg dexamethasone; by 24 hours post-treatment the differences were not as remarkable. A 
report (Mormede et al. 1980) on the pharmacokinetics of dexamethasone in pigs indicated that 
the neutrophilia and lymphopenia, commonly observed after glucocorticoid administration in 
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other species, peaked between 2 and 4 hours after treatment. By 24 hours post-treatment 
neutrophil and lymphocyte numbers were back to base line levels. These data (Saulnier et al. 
1991; Mormede et al. 1980) and the lack of any marked effects observed in Experiment 1 
could be explained by two hypotheses: The immunosuppressive dose of dexamethasone in 
pigs is greater than 2 mg/kg, or the period of immunosuppression may be less than 24 hours. 
Experiment 2 in this paper was designed to test these hypotheses. 
Materials and Methods 
Experiment 1: Repeated dexamethasone administration (2 mg/kg) 48 and 24 hours prior to 
sampling for immune function. 
Animals, Sample collection, and Assays 
Twenty crossbred pigs were obtained from the Iowa State University Swine Nutrition 
Farm. The pigs weighed 35-51 kg at the beginning of the two week acclimation period. The 
pigs were housed in raised pens, provided with adequate ventilation and sanitation, and were 
given food and water ad libitum. All animals were observed daily throughout the experiment 
and clinical signs were recorded. The pigs were a supplementary part of an experiment that 
has been previously reported (Goff et al. 1991). All samples and assays were performed as 
described previously in detail (Goff et al. 1991, These procedures are similar to the 
procedures described briefly in the next section of this dissertation in the Materials and 
Methods section under the heading In Vitro Immune Function). Samples for neutrophil and 
lymphocyte functions were collected three times during an eight day period at three different 
intervals approximately one month apart (Table 1 ). Dexamethasone was administered 48 and 
24 hours prior to each sampling. Each eight day interval containing three sampling days was 
considered a Period. These data were analyzed using a repeated measures analysis on the 
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three Period means of each animal as well as an analysis of variance on the individual Periods 
again using the Period means for each animal. The Periods were defined as indicated in 
Table 1. 
Treatments 
Ten castrated males and ten females were randomly assigned to two treatment groups 
of 5 castrated males and 5 females each (using a randomization that gave similar group mean 
weights). The treatments were administered by injection in the neck: 3 ml of 0.01 M 
phosphate buffered saline (PBS) or 2 mg/kg dexamethasone sodium phosphate (4.0 mg/ml). 
These pigs were part of a larger experiment (Goff' et al. 1991) involving a total of 60 animals. 
Because of the large number of animals involved in the larger study, the pigs were divided 
into two subgroups containing one-half of the animals from each treatment group. The two 
groups were then handled identically on consecutive days. That is, Day 0 for the second 
group was one day after Day 0 for the first group. A blocking factor was included in all 
statistical analyses to account for these two groups. Treatment and sex were handled as a 2 X 
2 factorial for statistical analysis. Treatments were administered as indicated in Table 1; these 
days represent 48 and 24 hours before blood collection for immune function assays plus four 
consecutive days (43-46) following tetanus toxoid administration. 
Experiment 2: Immune function testing 3 and 27 hours after a single dose of dexamethasone 
(2 or 6 mg/kg) 
Animals 
Thirty pigs (15 females, 15 castrated males) were blocked by weight (S 52.2 kg or > 
52.2 kg) and sex. Pigs within a weight/sex block were randomly assigned to one of 3 
treatment groups, 5 females, 5 males/group. Group mean weights were 53.5-54.5 kg; 
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individual weights ranged from 41 to 70 kg. Pigs were housed together, in an outside lot with 
an open front shed at one end. Food and water were provided ad libitum. 
Treatments 
Dexamethasone treated pigs received either 2 mg/kg or 6 mg/kg of dexamethasone-
sodium phosphate (Sigma Chemical Co. St. Louis MO) in distilled water (15 mg/ml or 
40 mg/ml respectively) administered by intramuscular (IM) injection in the neck. Control 
pigs received phosphate buffered saline by IM injection. The volume/kg was similar to that 
which the dexamethasone treated pigs received. Treatments were given once at 0500 hours. 
Blood was collected three times for immune function testing, as described for Experiment 1, 
at approximately 0800 hours, -45, 3, & 27 hours relative to treatment. 
In vitro Immune Function Assays and Hematology 
Lymphocyte blastogenesis to mitogens and the neutrophil function tests were 
performed as previously described (Goff et al. 1991). Cytochrome c reduction was not 
reported due to technical dififticulties. Total white blood cell counts and differentials were 
performed using an electronic particle counter and Wright stained blood smears, respectively. 
Statistics 
The raw data were analyzed using an analysis of variance at each time point that 
included a blocking term for sex and weight. Means of the dexamethasone treated groups 
were compared to the control mean using a Dunnett's test that controls the experiment-wise 
error rates for such comparisons. Lymphocyte blastogenesis data were converted to percent of 
control for display purposes only. 
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Results 
Experiment 1: Repeated dexamethasone administration (2 mg/kg) 48 and 24 hours prior to 
sampling for immune function. 
Dexamethasone treatment had similar effects in both males and females with a single 
exception: unstimulated lymphocyte blastogenesis during Period 1 (P<0.04 for sex x treatment 
interaction). 
Neutrophil Functions 
Most neutrophil functions were not altered by dexamethasone treatment (Table 2). 
Random migration was enhanced (P<0.05), and unstimulated cytochrome c reduction was 
decreased (P<0.05) in dexamethasone treated animals when the data were analyzed over all 
Periods, The individual Period data were similar to the overall results (data not shown). 
Lymphocyte Function 
Figure 1 depicts the lymphocyte blastogenesis data for Experiment 1. The 
lymphocyte proliferative response to phytohemagglutinin (PHA) was not affected by 
dexamethasone treatment. Proliferation in response to concanavalin A (ConA) and poke weed 
mitogen (PWM), as well as unstimulated proliferation, was significantly enhanced in 
dexamethasone treated pigs. This significant increase was observed both in individual Periods 
and when the data were analyzed over all three Periods (Figure 1). Production of tetanus 
toxoid specific IgG following vaccination was not different between control and 
dexamethasone treated pigs in Experiment 1 (Figure 2). 
Hematology 
Prolonged dexamethasone treatment caused significant (P<0.05) increases in 
neutrophil numbers during each eight day dexamethasone administration Period and at the end 
of the four day course of dexamethasone following tetanus toxoid vaccination (Figure 3). 
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Lymphocyte numbers tended to decrease throughout Experiment 1 in the dexamethasone 
treated animals (Figure 3). Monocyte and eosinophil numbers did not differ between the two 
groups in Experiment 1 (data not shown). Plasma protein values had transient significant 
increases during each dexamethasone administration Period of Experiment 1 (data not shown). 
During Experiment 1, packed cell volume remained stable (data not shown) in both groups, 
but hemoglobin concentration tended to decrease over time in the dexamethasone treated pigs 
(Figure 4). However, the mean hemoglobin concentration for the dexamethasone treated pigs 
stayed within the reference interval (Meyer et al. 1992). 
Serology 
All animals were seronegative for transmissible gastroenteritis virus and pseudorabies 
virus throughout the study. The titer to Actinobacillus pleuropneumoniae was not altered by 
dexamethasone treatment (data not shown). 
Weight Gain, Clinical Observations, and Organ Weights 
Dexamethasone treated pigs grew at a significantly (P<0.05) slower rate than the 
control animals (Table 3). Diarrhea was observed in 8 of the 10 dexamethasone treated pigs. 
The diarrhea was noted on one, two, or three separate days for each animal. These 
observations always occurred either during or immediately after a period of dexamethasone 
administration. One dexamethasone treated animal developed wire cuts/abrasions on a rear 
leg. These cuts were first noted on Day 40; the pig later developed a non-weight bearing 
lameness on this limb. The animal was euthanized on Day 59 to prevent further suffering. 
Another dexamethasone treated pig had a purulent ocular discharge as well as a large swelling 
near the left eye. This condition was first noted on Day 23, and resolved completely by Day 
43. Otherwise, all pigs remained clinically normal. On day 72 all pigs were euthanized by 
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exsanguination after being stunned by a captive bolt gun shot to the head. At necropsy, 
dexamethasone Seated pigs had larger (P<0.05) livers and kidneys, but significantly (P<0.05) 
smaller spleens (Table 3). 
Experiment 2: Immune function testing 3 and 27 hours after a single dose of dexamethasone 
(2 or 6 mg/kg) 
In Experiment 2 there were no significant differences between the groups prior to 
treatment in any of the ftinctions measured with one exception. Chemotactic migration was 
significantly higher (P<0.05) in the group that was to receive 6 mg/kg dexamethasone when 
compared to the control group. 
Neutrophil Functions 
Most neutrophil ftinctions were not altered at either post treatment sampling time by 
dexamethasone treatment (Table 4). Chemotactic migration was suppressed (P<0.05) in the 
6 mg/kg dexamethasone treated animals 27 hours after treatment. lodination in the 6 mg/kg 
dexamethasone treated pigs was suppressed three hours after treatment (P<0.05), but was 
enhanced in both dexamethasone treated groups 27 hours after treatment (P<0.05). Antibody-
independent cell-mediated cytotoxicity was decreased (P<0.05) in the 2 mg/kg dexamethasone 
treated group at three hours after treatment. 
Lymphocyte Function 
The lymphocyte blastogenesis data for Experiment 2 are shown in Figure 5. 
Dexamethasone administration caused a profound decrease in proliferative responses to all 
three mitogens 3 hours after treatment. However, this decrease was no longer significant 27 
hours after treatment. 
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Hematology 
Dexamethasone treatment caused a marked neutrophilia, lymphopenia, 
monocytopenia, and eosinopenia 3 hours after treatment in Experiment 2 (Figure 6). 
However, these values returned approximately to pretreatment levels by 27 hours after 
treatment. 
Discussion 
Pigs seem to be remarkably resistant to dexamethasone induced immunosuppression. 
Dexamethasone treatment resulted in only mild alterations in porcine neutrophil functions 
even at a dose that is 150 times higher than the dose that is consistently immunosuppressive 
in cattle. Previous work in cattle has shown that a single IM dose of dexamethasone at 0.04 
mg/kg will usually suppress bovine neutrophil antibody-dependent and -independent cell-
mediated cytotoxicity, iodination. Staphylococcus aureus ingestion, cytochrome c reduction, 
and random and chemotactic migration for greater than 24 hours (Roth et al. 1981; Roth et al. 
1982; Kaeberle et al. 1984; Pruett et al. 1987). Yet, in the two experiments reported here, and 
previous unreported work in our laboratory no consistent changes in neutrophil function of 
dexamethasone treated pigs were observed. No assay was significantly altered in both 
experiments. Random migration and unstimulated cytochrome c reduction were changed by 
dexamethasone treatment in Experiment 1. However, no significant alteration in random 
migration was noted in Experiment 2; cytochrome c reduction was not measured in 
Experiment 2 due to technical difficulties. Iodination was decreased three hours after 
treatment in Experiment 2, but was then significantly enhanced at 27 hours after treatment. 
Chemotactic migration and antibody-independent cell-mediated cytotoxicity were both 
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decreased in dexamethasone treated pigs in Experiment 2. The same changes were not 
observed in Experiment 1. 
The suppression of blastogenesis in lymphocytes from blood was quite transient. 
Lymphocjrte blastogenesis in Experiment 2 was profoundly suppressed 3 hours after treatment 
but had returned to control levels one day later. The increased proliferative response to ConA 
and PWM, but not PHA, observed in pigs treated repeatedly in Experiment 1 with 2 mg/kg 
dexamethasone is interesting. Previous workers reported an increase in the delayed type-
hypersensitivity response to intradermal PHA in dexamethasone treated pigs (Mann et al. 
1985). Unstimulated proliferation was also significantly enhanced in this same group of 
treated animals. This response was not evident when pigs were treated only once in 
Experiment 2, or in previously reported work (Saulnier et al. 1991). The increased response 
following dexamethsone treatment does not appear to be readily repeatable. Perhaps, other 
cofactors such as genetics or physiologic state play an important role in this event. These 
current observations confirm an earlier report of decreased blastogenesis to the mitogens PHA, 
ConA, and PWM at 3 hours after treatment with 6 mg/kg dexamethasone. At 24 hours only 
blastogenesis to PHA was significantly suppressed in the previously published work (Saulnier 
et al. 1991); however, there were no differences between the groups at 27 hours in 
Experiment 2. Further evidence that dexamethasone treatment did not cause long term 
suppressive effects on lymphocyte function is the normal production of antibody in response 
to tetanus toxoid in Experiment 1. Cattle treated with dexamethasone (0.04 mg/kg) usually 
produce antibody at a slower rate when they are compared to control animals (Roth et al. 
1984). 
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Expected hematologic changes were recorded after dexamethasone administration. 
The observed neutrophilia, lymphopenia, and eosinopenia in Experiment 2 at 3 hours after 
treatment reflect a typical stress leukogram (Meyer et al. 1992). The stress leukogram pattern 
is also seen after administration of synthetic glucocorticoids (Meyer et al. 1992). At 27 hours 
after dexamethasone treatment in Experiment 2, almost all hematologic values had returned to 
control levels. Neutrophil counts in the 6 mg/kg group had returned to the pretreatment level 
but remained significantly above the control group at this time point. Pigs that were 
repeatedly treated with dexamethasone in Experiment 1 had transient increases in neutrophil 
numbers; lymphocyte numbers tended to decrease with prolonged treatment. This decrease in 
lymphocyte numbers may reflect a reduction in lymphocyte production and/or increased 
lymphocyte destruction or tissue sequestration. The hematologic data presented here support 
earlier work. Mormede and More (1980) found that IV dexamethasone doses as low as 0.05 
mg/kg in pigs induced the characteristic hematologic changes seen after glucocorticoid 
administration in other species: neutrophilia, lymphopenia, and eosinopenia. Higher doses 
(0.2 mg/kg) did not augment the response. The peak response was between two and four 
hours after treatment, with all cell counts returning to base line levels by 24 hours after 
treatment. 
Dexamethasone administration does not appear to be a good immunosuppression 
model in the pig. Despite large drug doses, pig neutrophil ftjnctions seem to be remarkably 
resistant to suppression by dexamethasone treatment; lymphocyte blastogenesis was 
suppressed for only a few hours. The relative resistance of the porcine immune system to 
dexamethasone may be partially due to lower systemic drug concentrations. Frey, et al. 
(1988) found that pigs had an increased volume of distribution and increased clearance of 
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prednisolone after IV administration when compared to humans. Frey's results indicated that 
pigs would require 10 times the human dose of prednisolone to attain similar plasma levels 
(Frey et al. 1988). Common prednisolone doses used in humans are roughly equivalent, on a 
potency basis, to immunosuppressive dexamethasone doses used experimentally in cattle. To 
produce continuous immunosuppression in pigs, repeated dexamethasone doses at some 
interval less than 24 hours are indicated by the current results. Protocols for recrudescing a 
latent herpes virus (pseudorabies virus) in pigs may reflect the need for repeated doses of 
dexamethasone to sustain immunosuppression. One such protocol calls for administering 
4.6 mg dexamethasone/kg, divided in two doses on the first day, followed by four days of 
2.2 mg/kg/day dexamethasone, divided in two doses (Mengeling, 1989). 
Despite the minimal effects observed on immune function, ample evidence was found 
of the systemic effects of high doses of glucocorticoids in Experiment 1. The decreased 
growth rate observed has been previously reported in piglets treated with glucocorticoids 
(Chappie et al. 1989a; Chappie et al. 1989b). Hepatomegaly is often seen in animals 
suffering from hyperadrenocorticism, (Feldman, 1989; Haynes, 1990) and has been reported in 
pigs receiving hydrocortisone (Chappie et al. 1989a; Chappie et al. 1989b). The increased 
liver size may have resulted from increased glycogen stores due to the gluconeogenic effect of 
dexamethasone (Feldman, 1989; Haynes, 1990). The reduction in spleen weight is probably 
associated with the declining peripheral blood lymphocyte numbers; decreases in lymphoid 
tissue mass are commonly seen in animals with hyperadrenocorticism (Haynes, 1990). 
Diarrhea is a side effect associated with high doses of glucocorticoids (Plumb, 1991). Eight 
of the 10 pigs treated with dexamethasone in Experiment 1 developed diarrhea concurrent 
with or immediately following treatment. The small transient increases in plasma protein 
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observed in Experiment 1 may have been the result of dehydration. The pigs were housed in 
wire floor pens and used automatic nipple watering devices. Polyuria/polydipsia probably 
would not have been observed under these conditions. Polyuria/polydipsia is often one of the 
first clinical signs observed in dogs that develop hyperadrenocorticism (Feldman, 1989). 
Delayed wound healing caused by dexamethasone administration may have played a role in 
the traumatic lameness that necessitated the euthanasia of one animal in Experiment 1. 
From these many observations it is clear that dexamethasone administration at 
2 mg/kg caused significant systemic effects, with minimal impact on the immune functions 
measured. In summary, pigs seem remarkably resistant to immunosuppression by 
dexamethasone treatment. 
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Table 1: Experiment 1 Procedure Calendar 
Day of Experimeat 
0 7 14 21 28 35 42 49 56 63 70 
Period 1 | Period 2 | Period 3 1 
Dexamethasone D D D D D D D 
Immune Function Tests I I I I I I I I I 
Weight W W W W W W W W W W W 
Serology s S S s 
anti-Tetanus Toxoid Titer T T T T T T 
Tetanus Toxoid t 
CBC c C C C C C C C C 
The table indicates when various procedures were performed during Experiment 1. The procedures are on the left margin. A letter in the 
corresponding line indicates that that procedure (e.g. 'D' for Dexamethasone administration) was performed on the day of the experiment indicated 
by the horizontal position of the letter. Periods 1-3 for immune function testing Gymphocyte blastogenesis, and neutrophil fiinctions) are also 
indicated by the boxes at the top of the Table. 
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Table 2: In vitro neutrophil function results for Experiment 1. 
Assay Control Dexamethasone 
(2 mg/kg) 
SEM 
Random Migration (mm^) 49. *19 19 
Chemotactic Migration 
(directed/random) 
1.50 1.51 .17 
S. aureus ingestion (%) 26 29 4.9 
lodination (nm Nal/lO' pmn/hr) 51 45 13 
Unstimulated Cytochrome c 
Reduction (O.D. at 550 nm) 
0.12 *0.04 .09 
Stimulated Cytochrome c Reduction 
(O.D. at 550 nm) 
0.81 0.77 .08 
AICC (% specific lysis) 5.7 3.1 5.9 
ADCC (% specific lysis) 75 73 5 
Data are presented as the mean for each treatment group over all sampling days. Pigs 
received either dexamethasone (2 mg/kg) or saline 48 and 24 hours prior to each sampling. 
The pigs were sampled three times within eight days; this sampling period was repeated twice 
at one month intervals for a total of three periods. Period means had patterns similar to the 
overall means (data not shown). 10 pigs/group, * Differs from Control P<0.05, SEM 
Standard Error of the Mean. 
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Table 3. Growth Rate and Organ Size. 
Grovrth Rate and Organ Size Control Dexamethasone 
(2 mg/kg) 
SEM 
Body weight gain (Ibs/wk) 9.9 *7.5 6.0 
Spleen (% of body weight) .24 M6 .02 
(gm) 257 *168 16 
Liver (% of body weight) 1.55 *2.39 .07 
(gm) 1,707 *2,462 86 
Kidney (% of body weight) .31 *.39 .02 
(gm) 345 401 22 
Mean weight gain and organ size of pigs receiving dexamethasone 2 mg/kg on 22 of 71 days 
(n= 10). * Differs from control P<0.05. SEM Standard Error of the Mean. 
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Table 4: In vitro neutrophil ftinction results for Experiment 2. 
Hours Relative to Treatment 
Test Group -45 3 27 
Random Migration Control 149 98 87 
(mm^) Dex 2 154 116 109 
Dex 6 142 118 102 
Chemotactic migration Control 1.22 1.18 1.29 
(directed/random) Dex 2 1.24 1.24 1.21 
Dex 6 *1.39 1.26 '1.12 
S. aureus ingestion Control 38.2 40.4 44.6 
(%) Dex 2 34.9 41.8 49.8 
Dex 6 36.4 45.1 47.2 
lodination Control 46.7 37.7 35.4 
(nm NaT/10' PMN/hr) Dex 2 43.2 33.9 42.9* 
Dex 6 49.0 26.7* 42.4* 
Antibody-independent Control 3.5 3.6 2.5 
cell cytotoxicity Dex 2 2.5 2.3* 2.3 
( % specific lysis) Dex 6 3.0 3.0 2.4 
Antibody-dependent Control 72.9 65.7 75.9 
cell cytotoxicity Dex 2 71.9 66.4 74.5 
( % specific lysis) Dex 6 72.9 68.6 74.6 
Dexamethasone, either 2 or 6 mg/kg, was administered once at hour 0. Data are presented as 
the mean for each treatment and time combination (n=10). * Differs from Control, P<0.05 
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Figure 1: Mean blastogenic response of the dexamethasone (2 mg/kg) treated group in 
Experiment 1 (n=10). Data are presented as percent of the control group. 
Each Period represents three sampling days within eight days. Dexamethasone 
was administered 48 and 24 hours prior to each sampling day. The three 
Periods were spaced one month apart. The All Period data is the pooled data 
for all three Periods. Control group mean counts per minute for unstimulated, 
PHA, ConA, and PWM respectively are: Period 1 - 163, 18,300, 71,500, 
22,000; Period 2- 151, 20,000, 66,400, 26,600; Period 3 - 168, 41,200, 
79,700, 45,500. * Differs from control P<0.05. # Differs from control 
P<0.01. 
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Figure 2; Mean IgG, anti-tetanus toxoid titers from Experiment 1 ( Logj, n=10). • 
PBS Control, v Dexamethasone (2 mg/kg). Dexametiiasone was given for 
four consecutive days following vaccination, four consecutive days during 
Week 3, and two days at the end of Week 4. 
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indicated. • DifTers from control P<0.05. 
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Figure 4: Mean hemoglobin concentrations from Experiment 1 (n=10). • PBS Control, 
V Dexamethasone (2 mg/kg). Dexamethasone was given on the days 
indicated. •* Differs from control P<0.05. 
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Figure 5; Experiment 2 mean lymphocyte blastogenic responses of the dexamethasone 
treated groups presented as a percent of the control group (n=10). 
Dexamethasone (either 2 or 6 mg/kg) was administered once at hour 0. 
Control group mean counts per minute for hour -45, 3, and 27 respectively 
are: PHA 70,600, 22,100, 20,800; ConA 85,000, 7,300, 38,600; PWM 66,600, 
27,000, 19,000. Unstimulated mean counts per minute for all groups varied 
between 110 to 480. * Differs from control P<0.05. Differs from control 
P<0.01. 
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THE EFFECT OF BOVINE IMMUNODEFICIENCY-LIKE VIRUS INFECTION ON 
IMMUNE FUNCTION IN EXPERIMENTALLY INFECTED CATTLE 
A paper published in Veterinary Immunology and Immunopathology (1993,36:91-105) 
Kevan Flaming, Martin Van Der Maaten, Cecelia Whetstone, Susan Carpenter, Dagmar Frank, 
James Roth 
Abstract 
Bovine immunodeficiency-like virus (BFV) is a bovine lentivirus that has antigenic 
and genetic homology with the human immunodeficiency virus. Little work has been reported 
on the effect of BIV infection on bovine immune function. This study was designed to 
evaluate lymphocyte blastogenesis, mononuclear cell subset numbers, neutrophil function, 
hematology, and clinical signs in three groups of cattle. These groups were evaluated at 0-2 
months post inoculation (PI, group 1), 4-5 months PI (group 2), or 19-27 months PI (group 3). 
BIV infected animals were inoculated with the R-29 isolate of BIV in tissue culture cells, 
peripheral blood mononuclear cells from a R-29 infected calf, or a molecular clone of the 
R-29 isolate. Most inoculated animals seroconverted to BIV by Western immunoblot. BIV 
was reisolated from most of the animals inoculated. BIV infection was associated with an 
increase in the lymphocyte blastogenic response to the mitogen phytohemagglutinin in groups 
2 and 3. Neutrophil antibody dependent cell mediated cytotoxicity and neutrophil iodination 
were decreased (P<.05) in BIV infected cattle, (groups 2 and 3 and group 3 respectively). All 
animals were clinically normal during the evaluation periods. Notable differences were not 
observed in the other assessments performed. 
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Introduction 
Bovine immunodeficiency-liice vims (BIV) is a bovine retrovirus of tlie lentivirus 
subfamily that was first isolated from a dairy cow, R-29, with persistent lymphocytosis, 
progressive weakness and emaciation. At necropsy, lymph node hyperplasia and lymphocytic 
perivascular cuffing in the brain were noted. Inoculation of calves with the R-29 isolate 
resulted in enlargement and follicular hyperplasia of lymph nodes as well as a transient 
lymphocytosis (Van der Maaten et al., 1972). In serologic surveys, conducted on 
approximately 2200 cattle in the southern United States approximately 4% of the cattle tested 
had antibody against BIV (Amborski et al., 1989; Black, 1990). BIV has structural and 
antigenic similarity to the human immunodeficiency virus (HIV). Western immunoblot 
analysis and indirect immunofluorescence testing indicate shared antigenic epitopes of the gag 
(core) proteins of HIV and BIV. Sequence analysis of the 5' end of the BIV pol gene (which 
codes for reverse transcriptase) indicates 60% nucleotide sequence homology with other 
lentiviruses (HIV-1, equine infectious anemia virus, Visna virus, and caprine arthritis-
encephalitis virus)(Gonda et al., 1987). 
The culmination of HIV infection is clinically apparent as the acquired immune 
deficiency syndrome (AIDS). Yet, HIV infection does produce detectable changes in the host 
prior to the onset of AIDS. Infection with HIV has been associated with an acute "flu-like" 
syndrome shortly after seroconversion (Cooper et al., 1985). A decrease in CD4^ 
lymphocytes and an increase in CD8^ lymphocytes in the blood have been detected by 6 
months after seroconversion to HIV (Giorgi et al., 1989; Giorgi et al., 1987). B cell antibody 
production was reported to be compromised beginning at seroconversion, while T cell 
proliferative responses remained normal during the first 10 months (Terpstra et al., 1989). 
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Other workers reported decreased lymphocyte blastogenic responses to mitogens in HIV 
infected individuals who were clinically normal, but seropositive, with no estimate of the 
period of infection (Ridley et al., 1989). There have been few reports on the immunological 
effects of BIV infection in cattle. Interestingly, two calves were reported to have a selective 
depletion of CD4^ cells 3-4 months after inoculation with the original R-29 strain of BIV 
(Stott et al., 1989). Infection with BIV was also associated with decreased blastogenesis to 
mitogens in two calves 6 months after infection (Martin et al., 1991). Thus, there is evidence 
that measurable immune function changes following both HIV and BIV infection are present 
within a relatively short period of time after infection. The present study was designed to 
evaluate the effect of BIV inoculation on several measures of immune function in three 
groups of cattle at 0-2, 4-5, and 19-27 months post inoculation (PI). These three groups were 
used to define an optimal challenge inoculum for BIV and to characterize early pathogenic 
effects of BIV infection. 
Materials and Methods 
Group 1: Animals 0-2 Months Post-inoculation: Eight male holstein calves, aged 2-4 
months, were randomly assigned to either control (n=3) or BIV (n=5) inoculated groups. The 
control and inoculated calves were housed in separate rooms inside isolation facilities at the 
Veterinary Medical Research Institute, Ames lA. All of the animals were tested on days -24 
and 60 for antibodies to bovine syncytial virus (BSV), and bovine leukemia virus (BLV) by 
the agar gel immunodiffusion tests(Malmquist et al., 1969; Miller et al., 1976), and to BIV 
by Western blot analysis (Whetstone et al., 1991). Two animals appeared to have maternal 
antibodies to BLV or BSV. These animals were weakly positive when initially tested, but 
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eighty-five days later the same animals were negative for both viruses. All of the calves were 
seronegative for BIV before inoculation and were seronegative for BLV and BSV at 60 days 
PI. Of the five BIV inoculated animals, only three developed antibody against BIV. The 
results presented are from only the three BIV antibody-positive animals. 
Inoculum for Group 1 animals: Cell culture material infected with BIV, isolate R-29, 
was inoculated into a holstein calf of < 3 months of age. The BIV was then serially passed 
through 3 more calves by directly transfusing blood from an infected calf to a non-infected 
calf as previously described (Carpenter et al., 1992). This serial passage was done in an 
attempt to increase the virulence of the R-29 isolate and to obtain a challenge inoculum that 
was free of bovine viral diarrhea virus (BVDV), which is known to contaminate the R-29 
isolate. Peripheral blood mononuclear cells (PBMC) from the last infected calf were isolated 
by density gradient centrifiigation, resuspended in a solution containing 81% Eagle's 
minimum essential medium, 9% fetal bovine serum, and 10% dimethyl sulfoxide at a 
concentration of 2.5 x 10' cells/ml. The cells were frozen in a stepwise fashion: 12 hours at 
-20°C, 24 hours at -70°C, and then stored in liquid nitrogen. The inoculum produced BIV 
syncytia in cell culture, but did not contain BVDV when tested by indirect immunofluorescent 
assay. The frozen inoculum was rapidly thawed immediately prior to intravenous inoculation 
into the calves. Each of the five calves in the BIV group received 2.5 x 10' PBMC 
intravenously on day 0 of the experiment. Control animals received a like number of 
similarly freated cells from a BIV negative animal. 
Sample collection for group 1 animals: Blood was collected 2-3 times per week for 
hematologic evaluation during weeks -3 through 10. Blood (250ml) was collected twice per 
week of weeks -1 to 8, for in vitro immune fiinction analysis, described below. Mononuclear 
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cell subset analysis, and virus isolation were performed once per week. The animals were 
observed daily, and rectal temperatures were recorded three times per week. 
Group 2: Animals 4-5 Months Post-inoculation: Nine male holstein calves, 2-4 
months old, were randomly assigned to either control (5 animals) or BIV inoculated (4 
animals) groups. All animals were free of antibody to BIV (Western blot analysis), and BLV 
(agar gel immunodiffusion) at the beginning of the experiment. All of the animals but one 
BIV infected calf were free of antibody to BSV. The animals were housed together by group 
with the groups physically separated. 
Inoculum for Group 2 animals: The four BFV inoculated animals received fetal 
bovine lung (FBL) cell culture material that contained 1.8 X 10'' syncytium forming units of 
BIV R-29. Because this culture material was contaminated with a non-cytopathic strain of 
BVDV all animals were vaccinated with a commercial killed BVDV vaccine four and two 
weeks prior to inoculation. Control animals received FBL cells and were infected with a 
noncytopathic BVDV (provided by S.R. Bolin, NADC, Ames, lA). 
Sample collection for group 2 animals: Animals were evaluated twice during one 
week at both 4 and 5 months post inoculation for total and differential white blood cell count, 
neutrophil function, mononuclear cell subset analysis, and lymphocyte blastogenesis. 
Group 3: Animals 19-27 Months Post-inoculation: Eight cattle that had been infected 
with BIV for a period of 19 to 27 months were used in this experiment. Table 1 indicates the 
details of the individual animals. The seven (four female; three male) control cattle were 
from 2-5 years of age, and were either Holstein, Holstein-Angus crossbred, or 
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Charolais-Angus crossbred. All animals had no detectable antibody to BSV or BLV (agar gel 
immunodiffusion). Control animals were free of BlV-specific antibodies. All BlV-infected 
animals were negative for antibodies to BIV prior to inoculation. 
Inocula for Group 3 animals: The BIV infected animals received different inocula as 
described in Table 1. The BIV-106 molecular clone (provided by M.A. Gonda, Laboratory of 
Cell and Molecular Structure, Program Resources, Inc., NCI-Frederick Cancer Research 
Facility, Frederick, MD.) of the virus was derived from the original R-29 isolate of BIV 
(Braun et al., 1988; Garvey et al., 1990). Control animals received no inoculation. 
Sample collection for group 3 animals: All animals were tested at least twice during a 
3 week period for total and differential white blood cell count, neutrophil function, and 
lymphocyte blastogenesis. Mononuclear cell subset analysis was performed once for each 
animal. 
In Vitro Immune Function: Blood (250 ml) was collected by jugular venipuncture 
into acid citrate dextrose anticoagulant. Ai^er centrifiigation, plasma was discarded and the 
buffy coat was removed for mononuclear cell isolation by density gradient centrifiigation, as 
previously described (Roth et al., 1982). Neutrophils were isolated from the packed red blood 
cells (RBCs) by hypotonic lysis of the RBCs as previously described (Roth et al., 1981c). 
Isolated neutrophils were suspended in 0.015M phosphate-buffered saline solution (PBSS) at a 
concentration of 5.0 x 10' cells/ml for use in the functional assays. 
Neutrophil function assays were performed as described (Roth et al., 1981c; Steinbeck 
et al., 1986; Chiang et al., 1991). Briefly, random migration under agarose was measured 
after an incubation period of 18 hours; the area of random migration was reported in square 
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millimeters. Chemotaxis was measured by migration under agarose toward zymosan-activated 
serum; the chemotactic index was determined by dividing the distance of directed migration 
by the distance of random migration. Phagocytosis was measured using antibody-coated 
('"I)iododeoxyuridine-iabeled Staphylococcus aureus. Neutrophils were incubated for 10 
minutes with bacteria at a ratio of 60:1 (bacteria to neutrophil), then lysostaphin was added to 
remove the extracellular S. aureus: results were reported as percentage of bacteria ingested. 
Reduction of cytochrome-c, a measure of superoxide anion production, was evaluated after a 
30 minute (group 1) or a 5 minute (groups 2 & 3) incubation of neutrophils with 
cytochrome-c and opsonized zymosan. Results were reported as optical density/1.25 x 10® 
neutrophils/5 or 30 min. The iodination reaction, a measure of the myeloperoxidase -HjOj-
halide system, was measured by incubating neutrophils with opsonized zymosan and Na'^'l for 
20 minutes; the reaction was terminated by addition of trichloroacetic acid. Results were 
reported as nanomoles ofNal/lO' neutrophils/h. Antibody-dependent cell-mediated 
cytotoxicity (ADCC) was evaluated using antibody-coated "Cr-labeled chicken RBC as the 
target cell. The effector-to-target cell ratio was 10:1, and results were reported as percentage 
of specific release during a 2-hour incubation. Antibody-independent cell-mediated 
cytotoxicity (AICC) was measured similarly to ADCC; however, antibody was not added. 
Lymphocyte blastogenesis was performed, using pokeweed mitogen (PWM), 
phytohemagglutinin (PHA), and concanavalin A (ConA) as mitogens, with a 60 hour 
incubation period as described (Roth et al., 1982). Mitogens were used at concentrations that 
resulted in optimal stimulation of lymphocytes from control cattle. 
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Antibodies for Mononuclear Cell Subset Analysis: Primary antibodies were purchased 
from VMRD, Pullman WA. The hybridoma designation for each antibody follows the cell 
type the antibody was used to detect (Bo = Bovine): BoCD4 -CACT83B, B0CD8 
-CACT80C, BoCD2 -CH128A, B0CD6 -BAQ82A, B cells -BAQ44A, Monocytes -DH59B, 
Null(non-T, non-B, non-monocyte) cells -BAQ4A (Larsen et al., 1990; Davis et a!., 1987; 
Davis et al., 1988; Davis et al., 1991). Murine monoclonal antibodies against non-lymphocyte 
antigens were used as isotype controls. The fluorescein isothiocyanate (FITC)-conjugated 
goat anti-mouse IgG-IgM (heavy and light chain) second antibody was obtained from Caltag 
Laboratories (South San Francisco, CA). 
Mononuclear Cell Subset Analysis bv Flow Cytometry: Isolated PBMC were 
suspended in 0.015M PBSS, pH 7.4, containing 0.5 % bovine serum albumin and 0.1% NaNj 
(PBSS-H-) at a concentration of 5 X 10® cells/ml. Two hundred |il of cells were added to a U 
bottom microtiter plate. The plate was then centrifuged for 60 seconds at 160 X gravity. The 
supernatant was discarded and the cells were resuspended in 50 J.1I of the appropriate 
antibody, diluted 1:100 in PBSS-H-. The plate was incubated for 30 minutes on ice, then 
washed three times using PBSS-H-. A second 30 min incubation was performed in 50 |il of 
the 1:100 diluted FITC-conjugate. The cells were washed three times, resuspended, and fixed 
by the addition of 200 )il of a 1:1 mixture of PBSS and 2% paraformaldehyde in water. The 
plate was stored at 4°C, in the dark, until flow cytometric analysis was performed 1 to 5 days 
later. 
Flow Cytometry: A Coulter Epics 752 flow cytometer was used for data collection. 
Forward and right angle light scatter as well as fluorescein fluorescence were measured. 
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Gating, using forward and right-angle light scatter, was set such that any contaminating red 
cells or granulocytes were excluded from the analysis. Because of substantial overlap in the 
monocyte and lymphocyte populations the analysis was performed using the whole 
mononuclear cell population. Discriminators were set using the second antibody control for 
each animal so that background fluorescence was always less than 5% (2% for the 4-5 and 
19-27 month PI data) of the cells surveyed. For each sample, 5000 cells were analyzed. 
Hematology: Blood samples for hematologic evaluation were collected in evacuated 
blood collection tubes containing Na EDTA. Hemoglobin concentrations were measured by 
optical density. Total leukocyte counts were made using an electronic particle counter. 
Differential leukocyte determinations were made by examining 200 leukocytes on Wright 
stained blood smears. 
Seroloev and Virus Isolation: Western blot analysis and virus isolations by 
cocultivation with FBL cells were performed as previously reported (Whetstone et al., 1990; 
Whetstone et al., 1991). The ELISA titers reported for BIV are from an ELISA that detects 
antibody to the whole virus (manuscript in preparation, C. Whetstone). The virus is grown as 
previously described (Whetstone et al., 1991). Plates are coated with antigen (virus) in 
carbonate buffer, pH 9.6, and blocked with 0.1% bovine serum albumin + 0.2% Tween 20. 
Washes are carried out with 0.02% Tween 20 in 0.0IM PBS Ph 7.4. Negative control sera 
were negative at a 1:10 dilution. 
Statistical Analysis: The neutrophil fiinction, lymphocyte blastogenesis, mononuclear 
cell subset, and hematology data were analyzed by week of the experiment using a repeated 
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measures analysis of variance as appropriate for the group 1 data. The data from group 2 
were analyzed using a repeated measures analysis of variance. Similarly, the data from group 
3 were analyzed using a repeated measures analysis of variance including a blocking factor 
for the date of assay, since all animals were not assayed on the same day. A simple analysis 
of variance blocking on assay day was used for the mononuclear cell subset data of the 19-27 
month PI animals. 
Results 
Virus Recovery and Antibodv Response: All BFV inoculated animals developed BIV-
specific antibodies that were detectable by Western blot analysis, except that 2 of the 5 
inoculated animals in group 1 did not seroconvert. The data reported for group 1 is from the 
three antibody positive BIV inoculated animals. Virus was recovered from one of these three 
animals in group 1 at 60 days PI. BIV was reisolated from all animals in group 2 at both 4 
and 6 months PI. ELISA titers to BIV were 1:150 for all 4 animals in group 2 at the time of 
immune fiinction testing. In group 3 BIV was recovered from 3 of 8 animals. Virus recovery 
was not attempted on one animal and, recovery was unsuccessful from the other 4 animals in 
group 3 (Table 1). Titers to BIV by ELISA were 1:50 or 1:100 for all group 3 animals 
(Table 1). 
Clinical Signs and Hematoloev: All animals were clinically normal during the period 
of evaluation. There were no significant (P<0.05) differences noted in rectal temperatures or 
other clinical signs between control and BIV infected animals. The only hematologic measure 
(hemoglobin, total and differential leukocyte count) that was significantly different between 
control and BIV infected animals was that BIV infected animals at 19-27 months PI had 
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greater total leukocyte counts due to an increase in neutrophils (P<.05, BIV 3040 
neutrophils/(J.l ; Control 1980 neutrophils/|xl). 
Mononuclear Cell Subset Analysis: Based on the previous reports of 
lymphoproliferation and alteration in T cell subsets following BIV infection we were 
interested in evaluating mononuclear cell subset populations during these experiments. The 
only difference observed between BIV and control animals was an increase in the percentage 
of blood mononuclear cells identified as null cells in group 3 animals (Table 2). Null cell 
populations at 0-2 and 4-5 months PI were similar in BIV and control groups. The 
importance of the change in null cell populations is questionable since it only occurred in one 
group. Table 2 represents 60 comparisons of which one would expect to find 3 significant at 
the P<0.05 level by random chance. There were no differences in the percentages of cells 
identified as monocytes, B cells, CD 2* cells, CD 4^ cells, or CD 8^ cells in any of the groups 
tested (Table 2). Comparisons of the actual number of cells in each subset yielded similar 
conclusions. Data were reported as percentages because there were pronounced differences 
between the two 0-2 month groups prior to treatment. However, these relative differences 
were maintained throughout the experiment. 
Lvmohocvte Blastoeenesis and Neutrophil Function: The results of the lymphocyte 
blastogenesis assays indicated a tendency for BIV to increase the blastogenic response to 
mitogens. In eight of nine comparisons, the mean response of BIV infected animals was 
greater than control animals (Table 3). The response to PHA was significantly higher at 4-5 
months PI (P<.05) and nearly so again at 19-27 months PI (P<.06). The response to the other 
mitogens tested was not significantly altered by BIV infection. Neutrophil ADCC and AICC 
were both decreased (P<.05) at 4-5 months PI. lodination and ADCC were also decreased in 
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the BIV infected animals at 19-27 months PI (P<.03). Other measures of neutrophil function 
were not affected by BIV infection (Table 4). 
Due to the nature of lentiviral infections, the disease course may be expected to differ 
among animals. Therefore, in addition to the statistical analyses comparing groups of 
animals, the raw data were examined to determine if any individual animal or subset of 
animals deviated notably from normal in any of the various measures. None of the individual 
animals had any measures which markedly and consistently varied from normal. We also 
found no differences in groups 1 and 3 when comparing animals that virus was recovered 
from to those that virus was not recovered from. 
Discussion 
Taken collectively, these data indicate that BIV infection is capable of inducing 
alterations in the bovine immune system. Initially, no alterations were observed in animals 
tested three times a week for the first two months following infection. However, at 4-5 
months PI neutrophil ADCC and AICC were significantly decreased while lymphocyte 
blastogenesis to PHA was increased. At 19-27 months PI, neutrophil iodination, a measure of 
degranulation and oxidative metabolism, was decreased in addition to the decrease in ADCC. 
Lymphocyte blastogenesis to PHA was higher in BIV infected animals 19-27 months PI. The 
fact that decreased ADCC and increased blastogenesis to PHA were recorded in two separate 
groups of BIV infected animals adds to the significance of these observations. The increase 
in blastogenesis to PHA is consistent with the previous observations that BIV infection causes 
lymphoid proliferation rather than lymphoid depletion in infected cattle (Carpenter et al., 
1992; Van der Maaten et al., 1972). 
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Our observations differ from the previously reported decreases in lymphocyte 
blastogenesis (Terpstra et al., 1989) and in CD4 cell numbers (Stott et al., 1989) following 
BIV infection. Differences in inocula, concurrent infections, and individual animal variation 
may have contributed to the contrasting observations. The reported decrease in lymphocyte 
blastogenesis was observed at six months PI in two animals that were tested two and six 
months PI (Terpstra et al., 1989). We observed an increase in lymphocyte blastogenesis at 
4-5 months PI and 19-27 months PI. The previously reported decrease in CD4 cells occurred 
at 3-4 months after infection (Stott et al., 1989). Similar to our experiment, the calves in the 
previous reports were challenged with high passage BIV R-29 infected cell culture material 
that contained BVDV. Lymphoid depletion has been reported to follow lymphoproliferation 
in HTV and SIV infection (Gerstofl et al., 1989; Ost et al., 1989; Chalifoux et al., 1987). The 
decreased blastogenesis and drop in CD4^ cells may be a transient event which we did not 
detect. 
The R-29 isolate is the only reported isolate of BIV. However, this isolate of BIV 
had been passed multiple times in tissue culture, and it may have become tissue culture 
adapted, losing some of its original virulence. In addition, all available cultures of the R-29 
virus were also co-infected with a non-cytopathic strain of BVDV. The BVDV is known to 
induce neutropenia and lymphopenia, and to impair neutrophil and lymphocyte function 
during the first month after infection (Roth et al., 1981a; Roth et al., 1986; Tyler et al., 1965; 
Malmquist, 1968). In an attempt to increase the virulence and to obtain a challenge inoculum 
which was free of BVDV the R-29 isolate was serially passed through calves. The serial 
passage did succeed in eliminating the co-infecting BVDV, but apparently did not restore the 
R-29 isolate to its original virulence (Carpenter et al., 1992). The inocula given to the group 
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1 animals appears to liave been a minimal dose for BIV infection: only 3 of 5 seroconverted 
and virus was recovered from only one animal. Possibly, some virus viability was lost during 
the preparation and storage of the frozen inoculum used for this experiment. The lack of any 
immune function alterations observed in this group may have been due to the low virulence of 
the inoculum rather than the inability of BIV to cause such changes. A different method for 
preparing the inocula for the group 2 animals was used in an attempt to establish a more 
consistent infection. Immune function was not evaluated in group 2 animals until 4 months 
after infection to ensure that the BVDV present in the inoculum had been cleared by the 
animals. The R-29 virus, grown to a high titer in FBL cell cultures, proved to be a good 
challenge inoculum since all group 2 animals produced antibody, and BIV could be 
successfully recovered from them. 
BIV infection did not cause any clinical signs of disease in these animals. Therefore, 
the biological significance of the recorded alterations in immune function are not clear. Yet, 
similar decreases in ADCC and iodination have been observed in BVDV infected cattle and 
cattle treated with dexamethasone (Roth et al., 1981a; Roth et al., 1986; Roth et al., 1989; 
Roth et al., 1981b; Roth et al., 1984; Roth et al., 1985). Both BVDV infection and 
dexamethasone treatment have been associated with increased disease incidence. Neutrophil 
ADCC is thought to be an important antiviral mechanism for cattle. The myeloperoxidase -
HjOj-halide system, measured by the iodination assay, is a potent bacteriocidal mechanism of 
the neutrophil. A defect in this system may lead to increased susceptibility to bacterial 
infection. The animals in this study were housed in isolated groups and were not exposed to 
animals with clinically significant bacterial infections. 
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The effect of BIV may become more marked as the time after infection increases. 
This pattern would be similar to other mammalian lentiviruses. Recent studies have indicated 
changes in T cell subsets were detectable in feline immunodeficiency virus infected cats at 6 
months post-infection; deficits in proliferative responses to mitogens were progressive 
beginning at 6 months post-infection (Torten et al., 1991). During HIV infection, changes in 
T cell subsets are evident by six months after the first detection of serum antibody to HIV 
(Giorgi et al., 1989), however clinical disease is often not apparent for years. Ovine lentivirus 
infection usually occurs by colostral transmission shortly after birth, but the pneumonia 
associated with MaediA^isna is usually not observed until the animal is 2-3 years of age 
(Cutlip et al., 1988). In a like manner, the disease associated with caprine arthritis-
encephalitis virus may take months or years to develop (Cheevers et al., 1988). In contrast, 
the equine infectious anemia virus may induce clinical disease within several days after 
infection (Cheevers et al., 1988). 
BIV infection does appear to cause alterations in bovine lymphocyte and neutrophil 
function by 4-5 months after infection. Current inocula do not cause the degree of 
lymphocytosis induced by the original isolate. Following infected animals for a longer time 
after infection and work with additional isolates are needed to ftirther define the potential 
significance of BIV infection on the bovine immune system. 
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Table 1: Characteristics of the cattle infected with bovine immunodeficiency-like virus (BIV) for 19-27 months. 
Animal Sex Breed BIV Inoculation Age at 
Inoculation 
Age at 
Leukocyte 
Evaluation 
BIV BIV 
Isolation ELISA 
Titer 
246 M Jersey 
1029 F Holstein/Angus 
1034 F Holstein/Angus 
1049 M Angus 
1060 M Holstein/Angus 
1187 F Holstein 
1188 F Holstein 
1476 F Angus/Hereford 
R29 cell culture, IV 
R29 whole blood, 4th 
passage, IV 
BIV-106 clone cell-
culture-IV 
R29 cell culture, IV 
R29 whole blood, 2nd 
passage, IV 
BIV-106 clone cell 
culture, intracistemal 
BIV-106 clone cell 
culture, intracistemal 
BIV-106 clone cell 
culture, intracistemal 
10 months 37 months + 50 
5 weeks 20 months ND 100 
6 hours 23 months + 50 
8 months 29 months - 100 
3 weeks 21 months + 50 
3 months 26 months - 100 
3 months 26 months - 50 
3 months 26 months - 100 
Note: All cattle developed antibodies specific for BIV antigens after inoculation as detected by Westem blot analysis. 
They had no detectable antibodies to either bovine leukemia virus or bovine syncytial virus. 
IV = intravenous 
Table 2: Percent of peripheral blood mononuclear cells for BIV infected and control cattle. 
0-2 Months PI' 4-5 Months PI 19-27 Months PI 
BIV Control BIV Control Pr>F BIV Control Pr>F 
Cell n=3 n=3 n=4 n=5 n=8 n=7 
Bo CD4 24 24 24 24 .84 25 26 .93 
Bo CDS 11 12 12 11 .49 12 15 .34 
Bo CD2 / CD6 
(Pan 1*) 
33 34 34 33 .82 36 38 .77 
Null 15 13 16 15 .75 15 9 .03 
Monocyte 17 16 23 20 .58 15 14 .74 
B Cell 27 27 20 25 .16 25 28 .74 
Bo = Bovine 
Pr>F: The probability of having a greater F value for the comparison of BIV to Control groups simply by chance. 
n= number of animals per group 
' The means presented for the 0-2 month data are the mean for each treatment over all assay days. Data were analyzed weekly for 8 weeks 
post-inoculation, hence no Pr>F is appropriate for these means. No consistent significant differences were found between BIV and control 
animals. Occasional differences at P < .05 level did occur but the differences were not consistent and occurred at a frequency of less than one 
in twenty comparisons. 
'' Bo CD6 was used for the 0-2 month experiment (CD6 is expressed on most T cells and some B cells). Bo CD2 was used for the other two 
experiments (a Pan T marker). 
Table 3: Lymphocyte blastogenic response of peripheral blood lymphocytes from control and BlV-infected cattle to non-specific 
mitogens. 
0-2 Months PI' 4-5 Months PI 19-27 Months PI 
BIV Control BIV Control Pr>F BIV Control Pr>F 
Mitogen n=3 n=3 n=4 n=5 n=8 n=7 
Phytohemagglutinin (dcpm) 45700 29200 17900 8700 .03 26100 11900 .06 
Concanavalin A (dcpm) 21700 19800 17000 9400 .24 24900 14000 .15 
Poke Weed Mitogen (dcpm) 19000 29500 5800 2400 34 4800 3600 .18 
Unstimulated (cpm) 700 500 700 700 .92 600 320 .11 
Pr>F: The probability of having a greater F value for the comparison of BIV to Control groups simply by chance. 
cpm = counts per minute 
dcpm = difference in counts per minute (cpm with mitogen - unstimulated cpm) 
n= number of animals per group 
• The means presented for the 0-2 month data are the mean for each treatment over all assay days. Data were analyzed weekly for 8 weeks 
post-inoculation, hence no Pr>F is appropriate for these means. No consistent significant differences were found between BIV and control 
animals. Occasional differences at P < .05 level did occur but the differences were not consistent and occurred at a frequency of less than one 
in twenty comparisons. 
Table 4: Neutrophil function in BIV infected and control cattJe. 
0-2 Months PI' 4-5 Months PI 19-27 Months PI 
BIV Control BIV Control Pr>F BIV Control Pr>F 
Test n=3 n=3 n=4 n=5 n=8 n=7 
Random Migration (mm^) 39 42 33 38 24 28 33 2% 
Chemotaxis 
(directed/random) 
1.58 1.47 1.48 1.52 .63 1.54 1.63 .58 
S. aureus Ingestion (%) 25 24 36 35 .63 47 44 .42 
lodination (nm Nal/lO' 
PMN/hr) 
22 20 33 32 .52 38 52 .02 
Cytochrome C Reduction 
(O.D.) 
.65 .62 .75 .82 .17 .95 .96 .83 
AICC 
% specific lysis 
5.8 12.6 33 6.1 .03 2.8 3.5 .69 
ADCC 
% specific lysis 
48 53 38 53 .01 38 53 .02 
Pr>F: The probability of having a greater F value for the comparison of BIV to Control groups simply by chance. 
n= number of animals per group 
' The means presented for the 0-2 month data are the mean for each treatment over all assay days. Data were analyzed weekly for 8 weeks 
post-inoculation, hence no Pr>F is appropriate for these means. No consistent significant differences were found between BIV and control 
animals. Occasional differences at P < .05 level did occur but the differences were not consistent and occurred at a frequency of less than one 
in twenty comparisons. 
AICC = Antibody-independent cell-mediated cytotoxicity 
ADCC = Antibody-dependent cell-mediated cytotoxicity 
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Abstract 
This experiment was designed to evaluate the long term effects of single or dual 
infection with bovine immunodeficiency-like virus (BIV) and/or bovine leukemia virus (BLV) 
on bovine immune function. Holstein calves were infected with BIV (4 calves), BLV (5 
calves), BFV and BLV (5 calves), or sham inoculated (3 calves). Lymphocyte blastogenesis 
to mitogens, seven tests of neutrophil function, and mononuclear cell subset analysis by flow 
cytometry (BoCD4, B0CD8, BoCD2, BoWCl, slgM^, and Monocytes) were performed at 
regular intervals to 33 months post infection. These data were analyzed for main effects of 
each virus and interaction as a 2 X 2 factorial. BIV infected cattle had lower neutrophil 
antibody-dependent cell mediated cytotoxicity, and iodination responses during two of the 
three years post-infection (P <.05, first and third, and second and third respectively). BIV 
infection was not associated with any long term significant changes in lymphocyte 
blastogenesis to mitogens or changes in mononuclear cell subset numbers in blood. BLV 
infection caused an increase in total mononuclear cells with no dramatic shift in the relative 
proportions of the various subsets. Co-infection with BIV and BLV did not cause a different 
response than either virus did individually. One BIV infected animal died of non-BLV 
lymphosarcoma 7 months af^er infection. All other animals had no unusual clinical signs. In 
summary, infection with BIV caused significantly decreased neutrophil function with no 
alteration in lymphocyte blastogenesis or mononuclear cell numbers during the first three 
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years after infection. BLV infection caused an increase in lympiiocyte numbers, and tiiere 
appeared to be no synergism between the viruses. 
Introduction 
The bovine immunodeficiency-like virus (BIV, a lentivirus) has genetic similarities to 
other animal lentiviruses such as simian immunodeficiency virus, feline immunodeficiency 
virus and human immunodeficiency virus (HTV) (Gonda et al., 1987; Garvey et al., 1990). 
Clinically apparent immunodeficiency syndromes have been associated with infection by these 
other lentiviruses. BIV infection has not yet been shown to lead to a clinically apparent 
immunodeficiency syndrome. However, a recent abstract indicates that in a group of dairy 
cattle that died of various causes those animals that were seropositive for BIV had a higher 
rate of encephalitis and secondary infections (Snider et al., 1993). BIV was originally isolated 
from a dairy cow with persistent lymphocytosis, progressive weakness and emaciation (Van 
Der Maaten et al., 1972). More recent work has indicated that BIV has some measurable 
effects on bovine immune function. BIV infection has been associated with changes in 
lymphocyte blastogenesis (Martin et al., 1991; Flaming et al., 1993) and decreased monocyte 
ftmction (Onuma et al., 1992). Neutrophil iodination and antibody-dependent cell-mediated 
cytotoxicity were also reported to be decreased in BIV infected cattle (Flaming et al., 1993). 
Measurable changes in human immune function have been reported within a few 
months after HIV infection occurs and prior to the development of clinical signs associated 
with AIDS. lymphocyte numbers decrease by 6 months after the development of 
detectable antibodies to HIV (Giorgi et al., 1989; Giorgi et al., 1987). Non-specific 
lymphocyte blastogenesis appears to be decreased in HIV-seropositive, clinically normal 
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patients (Ridley et al., 1989). This experiment was designed to detect similar changes in BIV 
infected cattle. This report provides information on the immune fijnction of cattle infected 
with BIV and/or BLV through 33 months post infection. 
Bovine leukemia virus (BLV) was chosen as a coinfecting agent because BLV is a 
bovine retrovirus that is widely prevalent in the domestic cattle population, BLV also has 
genetic homology with human T cell leukemia viruses (HTLV) (Sagata et al., 1984). There is 
evidence that coinfection with HTLV and HIV may hasten the progression to AIDS 
(Schechter et al., 1994). Coinfection with HTLV-1 or HTLV-2 was associated with a higher 
death rate among HIV infected intravenous drug users (Page et al., 1990). In addition, an 
HTLV-1 regulatory protein has been reported to substitute for an HIV regulatory protein that 
promotes viral mRNA production (Felber et al., 1989). 
Materials and Methods 
Animals 
Seventeen castrated male Holstein calves, 2-4 months old, were randomly assigned to 
one of four treatment groups with a 2 X 2 factorial arrangement of BIV and BLV infection: 5 
calves were infected with BIV and BLV, 5 calves with BLV only, 4 calves with BIV only, 
and 3 calves were uninfected controls. All animals were free of antibody to BIV (Western 
blot analysis (Whetstone et al., 1991)) and BLV (agar gel immunodiffusion (Miller et al., 
1976)) at the beginning of the experiment. All of the animals but one BIV infected calf were 
free of antibody to bovine syncytial virus. All animals produced detectable antibody to the 
appropriate virus(es) after infection. The viruses, BIV and/or BLV, were recovered several 
times during the 33 months after infection from peripheral blood mononuclear cells of each 
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infected animal. The cattle were housed by group, outside, with the groups physically 
separated. Some of the animals in the current study have been previously reported on at four 
to five months post-infection (Flaming et al., 1993). 
Inoculum 
The BIV inoculated animals received fetal bovine lung cell culture material that 
contained 1.8 X lO"* syncytium forming units of BIV R-29. The BLV inoculated animals 
received 5X10' peripheral blood mononuclear cells from a Jersey cow with persistent 
lymphocytosis that was naturally infected with BLV. Because the BIV inoculum was known 
to be contaminated with non-cytopathic bovine viral diarrhea virus (BVDV) the BLV 
inoculated animals and control animals received a non-cytopathic BVDV along with their 
respective inocula. (Provided by S.R. Bolin, NADC, Ames, lA) All animals were vaccinated 
with a commercial killed BVDV vaccine 4 and 2 weeks prior to inoculation. 
Immune Function Testing 
Blood was collected by jugular venipuncture to allow isolation of leukocytes. Density 
gradient centrifugation was used to isolate mononuclear cells for flow cytometry (Roth et al., 
1981a). A lysis procedure was used to isolate neutrophils and mononuclear cells used in the 
lymphocyte blastogenesis assay. The neutrophil isolation procedure requires two hypotonic 
lysing steps to eliminate contaminating red blood cells after the bufly coat is removed from 
centrifiiged whole blood (Roth et al., 1982). The lysis procedure used for the mononuclear 
cells was similar to the neutrophil procedure with a few minor changes; after centrifugation 
of the whole blood, three ml of buffy coat and three ml of plasma were removed for lysing; 
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the neutrophil lysis procedure was then followed, adjusting volumes proportionally. Only one 
lysis cycle was used. Lymphocyte blastogenesis to the mitogens phytohemagglutinin (PHA), 
concanavalin A (ConA), and poke weed mitogen (PWM) was performed on isolated 
peripheral blood mononuclear cells as previously reported (Roth et al., 1982). Total and 
differential blood cell counts were performed using an electronic particle counter and Wright-
stained blood smears, respectively. Mononuclear cell subset analysis by flow cytometry was 
performed using primary antibodies purchased from VMRD, Pullman WA. The subset 
detected followed by the antibody clone were: BoCD4, CACT83B; B0CD8, CACT80C; 
BoCD2, CH128A; BoWCl (predominately y-5 T cells), BAQ4A; Monocytes, DH59B. Sigma, 
St. Louis MO was the source for the anti-Igm monoclonal antibody. The cell staining and 
flow analysis were performed as previously described (Flaming et al., 1993). A wide variety 
of neutrophil functions were analyzed as previously reported: antibody independent and 
dependent cell-mediated cytotoxicity against chicken red blood cell targets, iodination in 
response to opsonized zymosan, antibody opsonized heat- killed Staphylococcus aureus 
ingestion, cytochrome c reduction in response to opsonized zymosan, random migration under 
agarose, and chemotactic migration under agarose toward zymosan activated serum (Roth et 
al., 1981a; Steinbeck et al., 1986; Chiang et al., 1991). 
At each evaluation period, all of the above measures were performed twice within 
approximately one week. A total of 18 of these evaluation periods were spread between 2.5 
and 33 months PL Evaluation periods were at approximately four week intervals during the 
first year, six week intervals during the second year, and 12 week intervals during the third 
year. 
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Statistical Analysis 
Tlie data were analyzed as a completely randomized design with a 2 X 2 factorial 
arrangement of treatments. Main effects of BIV and BLV as well as viral interaction were 
examined. A main effect for a virus in a factorial design compares the mean of all animals 
infected with that virus against all animals not infected with that virus: e.g. a main effect of 
BIV would compare the BIV and BIV/BLV groups against the BLV and control groups. 
Interaction in a factorial design indicates that the effect of one (or both) virus(es) is not the 
same in cattle that are singly infected versus cattle that are dually infected. 
A primary aim of this research was to identify the long term effects of viral infection 
on immune function. Therefore, data are presented by year post-infection. A repeated 
measures analysis of variance was performed multiple times on the data by dividing the data 
by year post infection. 
Results 
One of the BlV-only infected calves died approximately 7 months after infection of a 
multicentric T cell lymphoma. A separate manuscript covers the findings on this animal 
(Rovid et al., 1994). No other animals had any unusual clinical problems throughout the 
study period. 
Infection with BIV caused no long term, significant alterations in mononuclear cell 
subset numbers (Table 1). Eosinophil numbers were significantly decreased (P < .05) in BIV 
infected animals in both the second and third year post-infection. Additionally, BIV infection 
had no prolonged effects on lymphocyte blastogenesis (Table 2). However, neutrophil 
antibody-dependent cell-mediated cytotoxicity and neutrophil iodination were significantly 
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(P < .05) decreased in BIV infected animals in two of three years post-infection (Table 3). 
The marked increase in migration values from year one to years two and three is most likely 
due to the use of different lots of fetal calf serum to prepare the agarose plates (Table 3). 
Similarly, the difference in the relative counts/min levels for lymphocyte blastogenesis of the 
three years is likely also due to differing lots of fetal calf serum used in the assay (Table 2). 
Infection with BLV did cause a significant increase in circulating mononuclear cell 
numbers. This increase appeared in the total mononuclear cell numbers and in all cell subsets 
(Table 1). One of the BIV/BLV infected animals had lymphocyte counts high enough to 
qualify as being persistently lymphocytotic (Thurmond et al., 1990) all three years (data not 
shown). In general, BLV infection did not alter the percentage of cells in the various subsets 
(data not shown), but did cause a significant increase in their total number (Table 1). 
Lymphocyte blastogenesis was altered by BLV infection. Proliferation in response to PWM 
was decreased (P < .05 main effect of BLV, Table 2) during the first year after infection. 
Conversely, the response to ConA was increased (P < .05 for main effect of BLV, Table 2) 
during the third year after infection. Blastogenesis in response to PHA was not consistently 
altered by BLV infection. BLV infection did not significantly alter the neutrophil functions 
measured during any extended interval (Table 3). 
There were few significant (P < .05) interactions between the viruses in the assays 
when evaluated in 12 month intervals. Neutrophil random migration did show a significant 
interaction (P < .05) during the first 12 months following infection. Animals infected with 
both viruses had a response similar to steers infected with BLV only but well above BIV only 
infected animals (Table 3). There was also a significant interaction between viruses in 
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neutrophil counts. Animals infected with either virus individually had lower neutrophil counts 
during the second and third years than the control or BIV/BLV groups (Table 1). 
Discussion 
Infection with BIV did not cause any clinically apparent immune dysfunction during 
the first three years after infection. However, one BIV infected animal did die of a 
multicentric T cell lymphoma seven months after infection. The association of BIV infection 
with the lymphoma is treated in a separate manuscript (Rovid et al., 1994). BIV infection did 
not cause any long term significant changes in white blood cell counts (except eosinophils) or 
mitogen stimulated lymphocyte blastogenesis. The changes in eosinophil numbers did not 
correlate with changes in neutrophil numbers and are relatively small in magnitude. We do 
not know the significance of this observation. Interestingly, the observed decreases in 
neutrophil iodination and ADCC were consistent with previous work. A heterogenous group 
of cattle that were tested together at varying times after they had been infected (19-27 
months) had significantly decreased neutrophil iodination and ADCC similar to the BIV 
infected cattle discussed here (Flaming et al., 1993). The neutrophil data from the BIV and 
control animals from the present report were previously described at 4-5 months post­
infection. At that time ADCC was significantly decreased in the BIV infected animals 
(Flaming et al., 1993). This trend held up over the first year, and remained numerically 
decreased in years two and three, becoming significant (P<.05) again in year three. 
Neutrophil iodination was also numerically decreased in BIV infected cattle all three years; 
significantly so in years two and three (P<.05). The clinical significance of these findings are 
unknown. Cattle with decreased neutrophil ADCC could be more susceptible to some viral 
infections. Decreased neutrophil iodination reflects a decrease in the activity of the 
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myeloperoxidase catalyzed oxidative killing mechanisms of the cell. No overt disease was 
noted in either group of animals. However, these cattle were housed under low stress 
conditions, with no exposure to other cattle that would be a potential source of new 
pathogens. These animals were probably not exposed to appreciable challenge doses of 
common bovine pathogens, so the lack of disease must be interpreted from that perspective. 
The observation that BIV infection did not cause any long term alterations on 
lymphocyte blastogenesis is in conflict with previous reports of decreased (Martin et al., 1991) 
and increased (Flaming et al., 1993) mitogen stimulated blastogenesis following BIV 
infection. The lymphoproliferative activity observed in the initial work on BIV may explain 
the previously observed increase in mitogen stimulated blastogenesis. Increased numbers of 
circulating lymphocytes were observed in calves from two separate experiments within the 
first few months after infection (Van Der Maaten et al., 1972; Carpenter et al., 1992). The 
current data represent more animals and a much longer time frame than the previous reports. 
All studies used the same R-29 BIV isolate for the inoculum. The BIV group mean for all 
three mitogens is substantially lower than the other groups particularly in years two and three. 
Yet the group infected with both BIV and BLV had a mean similar to the control and BLV 
groups. The lymphocyte blastogenesis assay is subject to large day to day variability. This 
fact coupled with the small sample size in the BIV group increased the variance estimate and 
perhaps masked an underlying interaction. If, in fact, BIV causes a decrease in lymphocyte 
blastogenesis, coinfection with BLV may act to block the decrease or restore normal 
proliferation in dually infected cattle. The tendency for decreased blastogenesis after 
prolonged infection may represent a different stage of BIV associated pathology than was 
observed in previous shorter experiments. In different individuals, lentiviruses cause clinically 
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apparent pathology at various times after infection. Therefore, one may not expect ail 
individuals in a group to develop lentiviral disease at the same time. 
Infection vk'ith BLV resulted in a relative increase in the numbers of circulating 
lymphocytes and monocytes. The actual number of cells tended to decline over time. This 
age related decrease is considered normal (Thurmond et al., 1990). However, relative to the 
non-BLV infected animals all lymphocyte subset numbers were increased. Only one of the 
steers could be classified as persistently lymphocytotic (Thurmond et al., 1990). Increases in 
both B and T cells have been previously reported in BLV infected animals (Williams et al., 
1988a). 
BLV infection had no long term affects on neutrophil function. Lymphocyte 
blastogenesis in BLV infected animals was significantly decreased during the first year post­
infection (PWM only) but significantly enhanced during the third year post-infection (ConA). 
The increase during the third year post-infection was relatively small when viewed as a 
percent of the control mean (<25%). The apparent decrease observed during year one 
disappeared during the second and third years. BLV infected non-persistent lymphocytotic 
cattle have previously been shown to have lymphocyte blastogenesis responses similar to 
uninfected animals (Williams et al., 1988b). Previous work has generally indicated that BLV 
infection does not affect immune function prior to the development of lymphoma or persistent 
lymphocytosis (Cockerell et al., 1986; Walker et al., 1987; Williams et al., 1988b; Meiron et 
al., 1985). 
There appeared to be little consistent viral interaction that influenced clinical signs or 
the variables measured. However, animals singly infected with either virus had lower 
neutrophil numbers than the control or BIV/BLV groups. Nevertheless, this pattern did not 
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correlate with the observed decreases in neutrophil fiinction and the numbers of neutrophils 
were generally within the normal range. Co-infection with BLV and BIV did not 
substantially alter the immune function responses measured during the first three years after 
infection. 
BIV infection has now been associated with decreased neutrophil ADCC and 
iodination in two groups of cattle and over an extended period of time. The observed 
decreases in these neutrophil functions are most likely due to an indirect effect of virus 
replication in other cells. BIV is known to infect macrophages, (Onuma et al., 1992; Rovid et 
al., 1994) and it is possible that BIV may infect lymphocytes. Either of these cell types are 
capable of modulating neutrophil activity through secreted cytokines. The magnitude of the 
decreased neutrophil function is similar to that we have previously observed in BVDV 
infected cattle (Roth et al., 1981b; Roth et al., 1983). Clinical experience indicates that cattle 
infected with BVDV are more susceptible to disease. Based on this evidence, BIV infection 
may make cattle more susceptible to disease as a result of decreased neutrophil function. BIV 
infection did not induce measurable changes in lymphocyte biastogenesis responses or 
mononuclear cell subset numbers during the first three years after infection. This experiment 
was designed to detect changes between the four treatment groups, and this methodology is 
relatively insensitive to individual animal variation. However, with the exceptions of the 
single persistently lymphocytotic BLV infected animal and the steer that died of 
lymphosarcoma, there were no other consistently remarkable individual findings. The lack of 
additional significant findings in BIV infected animals could be explained by different 
hypotheses. Perhaps, more time may be needed for altered immune function to develop or as 
81 
yet undefined co-factors may be needed. We plan to continue following these animals to see 
if immune dysfiinction develops in the future. 
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Table 1. White blood cell counts and flow cytometry data from BIV and/or BLV infected 
cattle (cells/|j,l). 
Year Post Inoculation 
1 2 3 
Total White BIV/BLV 12 ,230 10, 990^* 8, 33 0** 
Blood Cells 
BIV 9 , 030 7,340 5, 580** 
BLV 10 , 720 9, 870^* 7, 170** 
Control 10 ,220 8,580 7, 44 0** 
Std. Dev. 8 ,390 7,350 2, 950 
Neutrophils BIV/BLV 4 ,410 3,3 90** 2, 360*** 
BIV 3 , 020 2, 03 0** 1, 3 70*** 
BLV 3 , 540 3,180** 1, 840*** 
Control 4 ,520 3 , 500** 3 , 320*** 
Std. Dev. 4 , 880 2,190 1, 310 
Mononuclear BIV/BLV 7 ,470^* 7,320^* 5, 73 0^* 
Cells 
BIV 5 ,490 5, 000 3, 930 
BLV 6 840^* 6,250^* 4, 92 0^* 
Control 5 ,290 4,490 3, 700 
Std. Dev. 6 100 6,260 2, 630 
Eosinophils BIV/BLV 339 274^* 251^* 
BIV 522 311^* 282^* 
BLV 341 429 455 
Control 402 591 445 
Std. Dev. 842 698 316 
Table 1 continued. 
BOCD4 BIV/BLV 
BIV 
BLV 
Control 
Std. Dev. 
B0CD8 BIV/BLV 
BIV 
BLV 
Control 
Std. Dev. 
BoCD2 BIV/BLV 
BIV 
BLV 
Control 
Std. Dev. 
BoWCl BIV/BLV 
BIV 
BLV 
Control 
Std. Dev. 
sIgM* BIV/BLV 
BIV 
BLV 
Control 
Std. Dev. 
1, 921 1, 792 1,446 
1,455 1, 290 958 
1,632 1, 526 1, 401 
1, 512 1, 247 884 
1, 140 1, 534 520 
784"^ 982 740' 
646 762 552 
761^ 848 727' 
618 679 491 
540 990 370 
2,259 2, 399 2, 054' 
1, 860 1, 939 1, 502 
2, 005 2,126 1, 950' 
1, 873 1, 776 1, 304 
1, 240 1, 890 810 
1, 250 1, 340^^ 715' 
1, 057 998 487 
1, 216 1,266^ 796' 
906 819 543 
1,360 1, 670 480 
2,259^ 2,727^ 1, 893' 
1, 526 1, 729 964 
2,114^ 2,322^ 1, 626' 
1 , 2 9 0  1, 590 969 
2, 720 2 , 920 1,180 
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Table 1 continued. 
GMl* Monocytes BIV/BLV 
BIV 
BLV 
Control 
Std. Dev. 
1, 048 
1, 003 
964 
1,166^^ 766 
825 
773 
939^ 
728 676 
707 
566 
970 1, 140 290 
Main Effects of BLV ^ P< .10; P < .05; P < .01: This 
compares all BLV infected animals (BIV/BLV, BLV) against all BLV 
uninfected animals (BIV, Control) 
Main Effect of BIV ^ P< .10; P < .05; P < .01: This compares 
all BIV infected animals (BIV/BLV, BIV) against all BIV uninfected 
animals (BLV, Control) 
Factorial Interaction * P< .10; ** P < .05; *** P < .01: A 
significant interaction indicates that the effect of one (or both) 
virus (e.g. BIV) is not the same in cattle that are singly 
infected (BIV group) versus cattle that are dually infected 
(BIV/BLV). 
The data are the means from each year post infection. A repeated 
measures analysis of variance with a 2X2 factorial arrangement of 
treatments (BIV +/- and BLV +/-) was used to test statistical 
significance. There were a total of 21 test dates in year 1, 15 
in year 2 and 7 in year 3. 
Table 2. Lymphocyte blastogenic response to mitogens in BIV and/or BLV infected cattle. 
Year Post Inoculation 
1 2 3 
Pokeweed Mitogen BIV/BLV 17, 500^* 89,200* 95 , 500 
(Acpm) 
BIV 15,300 73,200* 83 , 500 
BLV 13,300^* 73,800* 96 , 000 
Control 20,900 84,500* 106 , 600 
Std. Dev. 11,400 46,000 36 , 600 
Concanavalin A BIV/BLV 34,000 142,400 168 , 300^* 
(Acpm) 
BIV 25,800 121,700 125 , 700 
BLV 31,500 137,200 167 , 400^* 
Control 33,700 143,500 162 , 400 
Std. Dev. 22,700 46,800 51 ,300 
Phyto- BIV/BLV 21,500 41,700 22 , 100 
hemagglut inin 
BIV 17,900 (Acpm) 25,300 7 , 500 
BLV 16,600 33,000 22 , 900 
Control 22,700 47,000 23 , 300 
Std. Dev. 18,300 65,100 42 , 800 
Unstimulated BIV/BLV 1, 370 4, 890 5 , 090 
(cpm) 
BIV 930 2,420 540 
BLV 1, 670 4, 850 3 840 
Control 1, 060 2, 880 2 , 480 
Std. Dev. 1, 960 9, 930 8 890 
Acpm = Stimulated cpm - Unstimulated cpm 
See Table 1 for an explanation of the superscripts. 
There were a total of 10 test dates in year 1, 13 in year 2 and 6 
in year 3. 
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Table 3. Neutrophil functions of cattle infected with BIV and/or BLV. 
Year Post Inoculation 
12 3 
Antibody-Dependent 
Cell-Mediated 
Cytotoxicity 
(% specific lysis) 
BIV/BLV 
BIV 
BLV 
42 
39 
45 
.4 
.9 
, 7 
25 
27 
28 
.2 
.2 
7 
32 
34 
40 
. 9 
.4 
.2 
J** 
I** 
Control 54 .5 42 8 54 1 
Std. Dev. 27 . 1 28 7 18 1 
lodination 
(nmol Nal/ 
10' PMN/hr) 
BIV/BLV 
BIV 
35 
37 
.2 
.1 
30 
30 
1 
1 
34 
34 
3 
5 
I* 
I* 
BLV 45 .7 31 2 41 7 
Control 38 .6 35 2 38 4 
Std. Dev. 10 .6 11 4 8 6 
Migration 
(mm^) 
BIV/BLV 
BIV 
43 
37 
X** 
x*» 
132 
117 
153 
146 
BLV 44 X**  129 156 
Control 50 X** 131 152 
Std. Dev. 12 8 36 . 0 35 5 
Antibody-
Independent 
Cell-Mediated 
Cytotoxicity 
(% specific lysis) 
BIV/BLV 
BIV 
BLV 
Control 
4 
6 
7 
9 
6 
7 
0 
0 
3 
5. 
3 
4 
2 
4 
7 
9 
7 
7. 
11 
11. 
6 
4 
2 
7 
Std. Dev. 13 3 9 7 12 3 
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Table 3 continued. 
Staph, aureus 
ingestion (%) 
BIV/BLV 42 6 52 7 29 2 
BIV 43 2 52 3 26 5 
BLV 42 9 53 6 29 0 
Control 41 7 49 2 26 5 
Std. Dev. 11 2 12 8 6 7 
Cytochrome c 
reduction (O.D. 
BIV/BLV 
BIV 
BLV 
Control 
Std. Dev. 
.75 
.77 
. 72 
.71 
.25 
1.05 ^ 
1.06 ^ 
1.12 
1.10 
.37 
. 77 
. 77 
. 78 
.79 
. 2 0  
Chemotactic 
migration 
(directed/random) 
BIV/BLV 
BIV 
BLV 
Control 
Std. Dev. 
1.44 
1.41 
1.39 
1.56 
.49 
1.30 
1.35 
1.28 
1.30 
. 11 
1.26 
1.32 
1.25 
1.30 
. 12 
See Table 1 for an explanation of the superscripts. 
There were a total of 17 test dates in year 1, 13 in year 2, and 5 
in year 3. 
GENERAL SUMMARY 
The review at the beginning of this dissertation discusses analyzing and interpreting 
immune function data. This chapter offers suggestions on proper analysis techniques for 
various types of data. Common errors in this field are also pointed out. The chapters that 
follow the review are examples of experiments that generate large amounts of immune 
function data. These experiments presented problems in data management and data analysis. 
Many of the problems discussed in the review are present within these experiments. 
The experiments in the second chapter explored dexamethasone administration as a 
potential model for immunosuppression in pigs. The experiments indicated that even 
relatively large doses of dexamethasone administered repeatedly over a period of weeks failed 
to consistently alter measures of immune function when the animals were tested 27 hours after 
dexamethasone administration. However, these same animals did exhibit other common signs 
associated with high doses of glucocorticoids. When pigs were tested only three hours after 
dexamethasone administration lymphocyte blastogenesis to mitogens was profoundly 
decreased. This measure of immune function returned to control levels by 24 hours after 
treatment. Neutrophil functions were relatively unaffected at either time. Dexamethasone 
administration appears to have limited use as a model for immunosuppression in the pig. 
Large doses, that can pose administration and/or cost problems, cause only transient 
suppression of lymphocyte blastogenesis and have little effect on neutrophil functions. 
The last two papers evaluate the effects of bovine immunodeficiency-like virus (BIV) 
on various aspects of immune function in cattle at varying times after infection. An 
immunodeficiency syndrome was not observed in any of the BIV infected animals, with a 
maximum post-infection time of 33 months. A consistent decrease in neutrophil iodination 
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and antibody-dependent cell-mediated cytotoxicity was noted in two groups of animals that 
had been infected for 18 to 33 months. This decrease is similar in magnitude to that seen in 
bovine viral diarrhea virus infected cattle, which are known to be more susceptible to various 
bacterial diseases. An increase in lymphocyte blastogenesis to mitogens was noted in two 
groups of BFV infected animals (4-5 months post-infection, 19-27 months post infection). 
However, this increase disappeared in the 4-5 month group at later testing times (through 33 
months). Other measures of immune function such as lymphocyte blastogenesis to mitogens, 
other neutrophil functions, white blood cell count, and lymphocyte subset populations were 
not consistently altered in BIV infected cattle. Coinfection with bovine leukemia virus did not 
alter the course of BIV infection. One of the BFV infected animals did die of a multicentric 
lymphosarcoma seven months after infection. None of the other animals exhibited any 
notable clinical signs after infection. 
